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Zusammenfassung
Die rezente Abwanderung der Pharmaunternehmen aus der neurologischen Forschung als
Folge einer grossen Zahl gescheiterter klinischer Studien mit Tausenden von Patienten hat
die Entwicklung neuer therapeutischer Ansa¨tze stark gebremst. Auf dem Gebiet der Ru¨ck-
enmarksverletzung ist die Situation noch gravierender: Patienten haben bisher weder einen
Zugang zu spezifischen Behandlungen, die die Verbesserung ihrer neurologischen Funktionen
zum Ziel haben, noch gibt es einen weltweit akzeptierten Versorgungsstandard.
Diese Vero¨gerung ist zum Teil darauf zuru¨ckzufu¨hren, dass klinische Studien seltener neurol-
ogischer Sto¨rungen zu den schwierigsten durchzufu¨hrenden Studien u¨berhaupt za¨hlen. Auf-
bauend auf den Meilensteinen historischer Arbeiten, befasst sich die vorliegende Dissertation
mit zwei Hauptmerkmalen klinischer Studien von Ru¨ckenmarksverletzungen, na¨mlich der
hohen Variabilita¨t der Erholungsmuster bei geringer Anzahl potenzieller Teilnehmer, sowie
der Analyse von facettenreichen neurologischen Endpunkten. Beide Aspekte gelten schon
lange als entscheidend fu¨r die Entwicklung effizienterer und wirksamerer Studien von Ru¨ck-
enmarksverletzungen und verwandten Disziplinen. In diesem Zusammenhang bedarf es im
Speziellen der Annahme innovativer und strengerer statistischer Methoden, die die derzeit
eingesetzten, aber fehlerhaften Ansa¨tze ersetzen sollen.
Wir suchten zuna¨chst einen Ansatz fu¨r die zuverla¨ssige Identifizierung und Stratifizierung
homogener Untergruppen innerhalb einer heterogenen Patientenpopulation. Durch die er-
stmalige Anwendung einer rekursiven Partitionierungstechnik, die auf bedingter Inferenz
basiert, wurde eine innovative Lo¨sung entwickelt, die auf einer eigens dafu¨r entwickelten
statistischen Methode basiert. Die Partitionierungstechnik soll die Planung ku¨nftiger klin-
ischer Versuche durch die Bereitstellung datengetriebener Entscheidungsregeln fu¨r Patien-
teneinschluss / -ausschluss und -stratifizierung verbessern. Ein Vergleich mit ga¨ngigen Strati-
fikationsmethoden hebt ausserdem mehrere Vorteile der rekursiven Partitionierung hervor. In
einem weiteren Schritt haben wir eine umfassende Analyse und Validierung unseres Ansatzes
implementiert, die eine flexible Vorlage fu¨r zuku¨nftige Studien bietet.
In einem abschliessenden Teil der Arbeit behandelten wir die Analyse komplexer kategorischer
Endpunkte, die allgegenwa¨rtig in der neurologischen Forschung und Ru¨ckenmarksverlet-
zungsstudien sind. Wa¨hrend Routineanalyseansa¨tze annehmen, dass sogenannte Multiple-
Item-Rating-Skalen kontinuierliche Endpunkte liefern, sind diese Ansa¨tze durch starke Ein-
schra¨nkungen fehlerhaft. Wir haben zuna¨chst ein ordinales Regressionsmodell auf die spez-
ifischen Bedu¨rfnisse von klinischen Studien von Ru¨ckenmarksverletzungen ausgerichtet, die
zu erheblichen Verbesserungen in Bezug auf die statistische Aussagekraft und klinische Inter-
pretation fu¨hrten. Schliesslich beurteilten wir die Messeigenschaften von Rating-Skalen und
deren Langzeitmodellierung auf der Basis von latenten Variablenmodellen, die ein wesentlich
strengeres und anspruchsvolleres Rahmenwerk fu¨r die Analyse neurologischer Endpunkte
liefern.
Durch die Erarbeitung wichtiger Aspekte der Patientenintegration und deren Stratifizierung,
sowie der Endpunktanalyse zielten wir darauf ab, Planung und Analyse klinischer Studien
zu verbessern, insbesondere die der Ru¨ckenmarksverletzungen, sowie neurologischer Sto¨run-
gen im Allgemeinen. Unsere Hoffnung ist, dass die neu erarbeiteten Ansa¨tze synergistisch
den klinischen Prozess schnell voranbringen ko¨nnen und so zu spezifischen therapeutischen
Behandlungen fu¨r Menschen mit Ru¨ckenmarksverletzungen fu¨hren werden.

Abstract
The departure of drug companies from neurological research as a consequence of a large num-
ber of failed clinical trials involving thousands of patients strongly braked the development of
new therapeutic approaches. The situation is even more acute in the field of spinal cord injury,
where patients have yet to gain access to a first specific treatment for improving neurological
function or witness the introduction of a globally accepted standard of care.
The lagging translation process is due to the fact that clinical trials in rare neurological disor-
ders are among the most challenging to conduct. Building on the important lessons provided
by historical trials in the path to translation, this thesis addresses two major peculiarities of
spinal cord injury trials, namely the high variability of recovery patterns among the small
number of potential participants and the analysis of multi-faceted neurological endpoints.
Both aspects have been recognised as crucial for the development of more efficient and ef-
fective trials in spinal cord injury and related disciplines. In this context, the adoption of
innovative and more rigorous statistical methods replacing currently employed but flawed
approaches is required.
We first seek an approach for the reliable identification and stratification of homogeneous
subgroups within a heterogeneous patient population. By applying for the first time in the
field an unbiased recursive partitioning technique based on conditional inference, we pro-
vided an innovative solution based on a statistical method specifically developed for this
purpose. This partitioning technique is intended to improve the planning of future clinical tri-
als by providing data-driven decision rules for patient inclusion/exclusion and stratification.
A comparison with commonly employed stratification methods highlights several advantages
of recursive partitioning. In a further step, we implemented a comprehensive analysis and
validation of our approach, providing a flexible template applicable to future studies.
Subsequently, we dealt with the analysis of complex categorical endpoints, which are ubiqui-
tous in neurology and spinal cord injury. While routine analysis approaches assume multiple-
item rating scales to deliver continuous endpoints, these approaches are flawed by severe
limitations. We first adapted an ordinal regression model to the specific needs of spinal cord
injury trials, which lead to substantial improvements in terms of statistical power and clinical
interpretation. Finally, we assessed measurement properties of rating scales and their lon-
gitudinal modelling based on latent variable models, providing a much more rigorous and
sophisticated inferential framework for the analysis of neurological outcomes.
By addressing both key issues of patient inclusion and stratification as well as endpoint anal-
ysis, we aimed at providing essential elements for a better planning and analysis of clinical
trials in spinal cord injury in particular, and neurological disorders in general. Our hope is
that they may synergistically fast-forward the clinical process leading to specific therapeutic
treatments for people living with spinal cord injury.
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Introduction
Just as the scientific understanding of brain plasticity has reached new heights, drug compa-
nies started turning their backs to neurological disorders. A number of failed clinical trials
involving thousands of patients prompted companies to divert their investments to other med-
ical fields. While the failure of any clinical trial can be usually ascribed to multiple reasons,
the poor choice of primary endpoints and their analysis pose a common threat to neurological
studies. In addition, rare neurological diseases such as spinal cord injuries are further charac-
terised by few potential patients, but a large heterogeneity in terms of spontaneous recovery
patterns. Clinical trials in rare neurological diseases are therefore among the most challenging
to conduct. The complexity of the situation is reflected by the fact that after three decades of
clinical research, there is still not an approved treatment for improving neurological function
nor a consensus standard of care specific to people who suffered a spinal cord injury.
A historical review of mainly failed spinal cord trials in the path to translation has nonetheless
provided important lessons for improving future trials conduct. Especially trial design, the
choice of the primary outcome and its analysis plan were identified as key elements that
require the application of innovative and more rigorous statistical approaches. This thesis
pursued thus two aims which are meant to synergistically contribute to the development of
more efficient and effective clinical trials in spinal cord injury and related disciplines.
Our first aim was to propose an innovative approach for the reliable stratification of homoge-
neous participant subgroups within a heterogeneous neurological disorder such as spinal cord
injury. Given the additional constraints posed by the rare disease status, a necessary condition
was to propose a framework which allowed to include as many participants as possible in a
sensible manner. This was achieved in Paper I and Paper II of this thesis, where we applied for
the first time in the field the unbiased recursive partitioning technique called conditional in-
ference tree to improve the planning of future clinical trials by providing data-driven decision
rules for patient stratification and inclusion/exclusion.
Our second aim was to further develop and tailor statistical methods used to analyse complex
ordinal endpoints generated by multiple-item rating scales. Although this kind of endpoint is
ubiquitous in neurology and spinal cord injury, commonly used analysis approaches routinely
assume more refined measurement scales (e.g. continuous endpoints). These approaches in-
troduce several limitations and represent a major weakness of the translational process. To
address this issue, Paper III and Paper IV propose two ordinal models that represent specific
solutions to the analysis of complex ordinal endpoints and highlighted drawbacks of currently
employed approaches in spinal cord injury.
All analyses conducted in this thesis are intended to promote more efficient and effective
clinical trials by overcoming major weaknesses of the current translational process in spinal
cord injury. Both key areas of patient stratification/inclusion as well as endpoint analysis
were addressed with innovative and more rigorous statistical approaches, which may further
act as templates for similar scientific endeavours across medical disciplines.
- 1 -
1 Neurological research
Neurological research is responsible for the investigation of many devastating disorders such
as stroke, Alzheimer and Parkinson, among others. Besides impairment and sufferance, brain-
related disorders are a greater socio-economic burden than cancer, cardiovascular diseases and
diabetes combined (Gustavsson et al., 2011). With yearly costs for the European society esti-
mated at almost 400 billion e (Andlin-Sobocki et al., 2005), the economic potential of any drug
obtaining approval from regulatory agencies set a strong incentive for drug development. In
fact, the translational process, which starts from promising experiments in the laboratory and
results in effective treatments safely applicable to humans, experienced a sustained accelera-
tion at the turn of the century.
More recently, though, health insurers and drug companies have withdrawn from neuro-
science as a consequence of a large number of failed trials involving thousands of patients
(Schwab and Buchli, 2012). This unfortunate development occurred despite the concomitant
unparalleled evolution of preclinical discoveries with high potential for translation to human
cure. Mechanisms of cellular and molecular regeneration occurring at the lesion site, and
the possibility to actively regulate them, have created the premises for several therapeutic
approaches (Thuret et al., 2006; Tator, 2006; Hawryluk et al., 2008; Liu et al., 2011). Function-
blocking antibodies (Zo¨rner and Schwab, 2010), stem cell therapies (Antonic et al., 2013), and
growth-promoting immunotheraphy (Wahl et al., 2014) are some of the most recent investiga-
tory lines potentially leading to human therapies.
Given all these research lines generating very promising outcomes in more controlled settings,
the question arises as why those approaches have failed to deliver treatments in the clinical
context. It is certainly true that the failure of any clinical study cannot be reduced to a single
aspect. Nonetheless, the choice of a primary endpoint and its analysis plan are very often
criticised for being crude, not well defined, or poorly analysed (Hobart, 2003; Bath et al.,
2007; Hobart et al., 2007; Lammertse, 2012; Schwab and Buchli, 2012; Maas et al., 2013). We
therefore maintain that a prominent weakness of the translational process is to be located
in the statistical analysis methods used to test for treatment efficacy, especially concerning
multiple-item rating scales used to measure health outcomes in patients with neurological
disorders.
1.1 Multiple-item rating scales are ubiquitous
Virtually all routinely performed clinical assessments in neurological diseases and spinal cord
injury are multiple-item questionnaires. Consequently, virtually all potential primary and
secondary endpoints are delivered by multiple-item rating scales as well. Above and beyond
considerations related to the clinical validity of this type of endpoints, this data format is
characterized by an arbitrary numerical scale merely establishing a ranking of observations
at item level. This introduces often overlooked statistical properties that, if not considered
properly, have the potential to invalidate analyses.
Firstly, despite the numerical labels in the form of successive integers assigned to them, the
difference between two following ranks is by no means bound to be equivalent across the
range of the rating scale (Hobart, 2003). This feature prevents standard mathematical opera-
tions such as addition and multiplication, and makes the use of statistical methods developed
for continuous outcomes inappropriate already at item level. Secondly, multiple-item rating
scales are hardly ever unidimensional measurement tools (Hobart et al., 2007). Instead, neu-
rological multiple-item rating scales usually track a combination of several health domains.
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Even Patient Reported Outcomes are usually analysed as a measure of a single health domain,
although they have specifically been developed to capture patients’ multifaceted perspective
(Chow et al., 2009). While this may seem to be a rather theoretical issue with little relevance
for clinical practice, it is akin to having a “scale that measures length at one end, weight in
the middle, and volume at the other end” (Hobart, 2003). Especially with regard to the issues
outlined above, assuming continuous interval-scaled endpoints in the presence of rating scales
has been shown to be inappropriate in a number of aspects (Agresti, 2010). Biased parameter
estimates, misleading associations and loss of power are some of the known consequences of
its disregard (Winship and Mare, 1984; Hastie et al., 1989; Scott et al., 1997).
1.2 An overall score is commonly adopted, but generally not valid
Nonetheless, measurements from multiple-item rating scales are usually taken at face values
and combined into a summed total score. The latter is then handled as a single, interval-
scaled endpoint for analysis (Bracken et al., 1984, 1990; Geisler et al., 1991; Bracken et al., 1997;
Cardenas et al., 2007). Despite being heavily employed, the practice of adding several ordinal
items to form a single overall score is generally not valid with regard to the assumptions
of unit change and unidimensionality exemplified above, and has been repeatedly reported
in neurological and related physical functioning settings (McHorney et al., 1997; Ravaud et
al., 1999; Fink et al., 1999; Luther et al., 2006; Catz et al., 2007; Hobart et al., 2007). The issue
of inappropriate statistical analyses of ordinal data delivered by rating scales is not new in
medicine (Forrest and Andersen, 1986), but has assumed an unprecedented magnitude in
neurology, where ordinal measurements generated by multiple-item rating scales are often the
only type of data which clinical assessments provide and therefore what neurologists have to
work with (Hobart, 2003). Yet, the rapid spread of questionable analysis approaches cannot
be justified on scientific terms, as the statistical framework for the analysis of complex ordinal
endpoints is already in place (Agresti, 2010; Tutz, 2012), and has been rapidly expanding ever
since the formulation of the first approach to ordinal regression models (the proportional odds
model by McCullagh, 1980). Especially the social sciences have been very active in this area
of statistics, as categorical and particularly ordinal outcomes are the hallmark of their field
(De Boeck and Wilson, 2004; von Davier and Carstensen, 2007). Similar approaches have been
sporadically proposed in the field of medical statistics (Laffont et al., 2014; Conigliani et al.,
2014), but are rarely applied in neurological and clinical research.
2 Spinal cord injury
In addition to the issues of crude endpoints and flawed analysis strategies common to all
neurological disciplines, rare neurological diseases such as spinal cord injury are further char-
acterised by few patients that can be potentially recruited for a study (Wyndaele and Wyn-
daele, 2006), but a large heterogeneity in terms of spontaneous recovery patterns (Fawcett et
al., 2006). This peculiarity of spinal cord studies may lead to distortions of trial results, as the
contribution of a small number of participants with heterogeneous characteristics may drive
efficacy testing and outcome interpretation in one direction, independently of the real value
of the treatment. Also, subtle treatment effects could be overcast by the inherent heterogene-
ity of recovery patterns, leading to premature abandonment of promising research lines. To
prevent these deleterious issues, but also to accommodate the limited number of potentially
appropriate trial participants available for an ever increasing number of new interventions, the
recruitment of participants needs to be developed in a more inclusive and effective manner.
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2.1 Inclusion/exclusion and stratification of trial participants
While applying narrow inclusion criteria may be justified in early trial phases focusing on
safety, their enforcement implies slow trial progress, with negative consequences for the timely
and financially sustainable accomplishment of the planned goals. In addition, a narrow re-
cruitment strategy is inefficient, as it provides results only applicable to a narrow subpopu-
lation, requiring therefore additional studies for spinal cord participants with other charac-
teristics. Therefore, once treatment safety is established, a more inclusive strategy that enrols
participants with varying degrees and sites of lesions should be preferred. Such a strategy is
more efficient and generates knowledge that concerns a large patient population. In addition,
participants with incomplete lesions are more likely to benefit from interventions targeting
their spared sensorimotor function (Tuszynski et al., 2006). The inclusion of participants with
incomplete lesions is further justified by the fact that many experimental treatments being
translated were developed using animal models with incomplete lesions (Kwon et al., 2002).
There are therefore a number of important reasons to develop an inclusive enrolment strategy
that will allocate the few trial participants available efficiently, ensuring that a large scientific
gain is brought about by the timely and financially sustainable completion of clinical studies.
However, the enrolment of participants with varying degrees of lesions poses specific chal-
lenges (Tuszynski et al., 2006). Besides safety challenges, participants with incomplete spinal
cord lesions comprise a highly heterogeneous population in terms of level and severity of
injury, as well as the diversity of recovery patterns (Fawcett et al., 2006). Historical trials with
broad inclusion criteria (Bracken et al., 1984, 1990; Geisler et al., 1991; Bracken et al., 1997;
Geisler et al., 2001b; Dobkin et al., 2006; Cardenas et al., 2007) emphasised the necessity to
implement stratification algorithms to limit subject heterogeneity within study cohorts. In ad-
dition, the exclusion of those patients whose spontaneous recovery is so extensive that would
mask any therapeutic benefit must be guaranteed. In summary, the ability to capitalise on
a more inclusive recruitment approach requires the ability by trial scientists to prospectively
single out clinically relevant subgroups of patients. This capability not only would allow the
targeted inclusion/exclusion of participants and provides an a-priori stratification template,
but also enables the formulation of strata-specific endpoints in future trials.
3 Fast-forward the lagging translational process
Despite the optimism sparked by the understanding of mechanisms of neuronal degenera-
tion and regeneration (Kleitman, 2004), the promises of preclinical discoveries have yet to be
translated into a standard care of treatment (Lammertse, 2012). To consolidate the efforts of
the field to continually improve the conception of clinical trials, the International Campaign
for Cures of Spinal Cord Injury Paralysis (campaignforcure.org) appointed in 2007 an interna-
tional panel with the task of reviewing strengths and weaknesses of past clinical trials in spinal
cord injury. Their recommendations were condensed in four publications, addressing issues
such as patients’ spontaneous recovery patterns (Fawcett et al., 2006), clinical trial endpoints
(Steeves et al., 2006), trial inclusion and exclusion criteria (Tuszynski et al., 2006), and clinical
trial design (Lammertse et al., 2006). While providing important guidelines that effectively
influenced the conception of following clinical trials (Sorani et al., 2012), the reviews did not
solicit the application of the most appropriate and rigorous statistical approaches with regard
to patient stratification and trial outcome analysis. This thesis tackles both issues of patient
inclusion as well as endpoint analysis, providing therefore not only much-needed principles
for decision-making in the clinical setting, but also essential, yet missing elements for a bet-
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ter planning and analysing of clinical trials in neurological disorders. Ultimately, our results
are intended to fast-forward the clinical process leading to specific therapeutic treatments for
people living with spinal cord injury.
4 Upper Extremity Motor Scores as primary endpoint
In our specific neurological setting, the trial endpoint considered is the Upper Extremity Motor
Score (UEMS). UEMS represents a subset of the International Standards for Neurological
Classification of Spinal Cord Injury and describes the muscle contraction force for 10 key
muscles on the arms and hands (see Figure 1). Each key muscle is rated on a 6-point ordinal
scale (0: total paralysis, through 5: active movement against full resistance) (Kirshblum et
al., 2011) . Accordingly, Yi,m,t is the muscle contraction score for patient i (i = 1, ..., n) and
key muscle m (m = 1, ..., 10) measured at time point t (t = 1, ..., 5). Each key muscle Yi,m,t is
therefore an indicator with k = 6 levels 0 < 1 < ... < 5, and UEMS is a multiple-item rating
scale. The chosen endpoint is particularly relevant in spinal cord injury research. Total UEMS
or its change over trial period has been employed repeatedly in clinical trials (Bracken et al.,
1984, 1990; Geisler et al., 1991; Bracken et al., 1997; Cardenas et al., 2007; Casha et al., 2012) and
has been suggested to correlate with changes in activities of daily living that rely on recovery
of upper extremity function (Rudhe and van Hedel, 2009).
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NT = not testable
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Patient Name_____________________________________   Date/Time of Exam _____________________________
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Figure 1.: International Standards for Neurological Classification of Spinal Cord Injury
All the analyses conducted in this thesis are based on data kindly provided by The European
Multicenter study about Spinal Cord Injury (emsci.org, ClinicalTrials.gov). The European
Multicenter study about Spinal Cord Injury encompasses 19 paraplegic centres across Europe
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with the aim to foster close collaboration to discuss, plan and realise prospective studies in-
volving participants who suffered a spinal cord lesion. Patients deferred to member centres
who comply with clearly defined inclusion criteria are tested and documented within a fixed
time schedule (1, 4, 12, 24 and 48 weeks) after spinal cord injury. The European Multicenter
study about Spinal Cord Injury has been tracking the functional, neurological and neuro-
physiological status of patients during the first year of recovery in a rigorously standardized
manner since 2001. The papers composing this thesis are therefore retrospective analyses of
prospectively collected neurological data.
5 Planning a study: inclusion/exclusion and stratification
Given the limited pool of individuals who suffer spinal cord injury (Sekhon and Fehlings,
2001), but also the necessity to include participants with varying degrees of injuries to match
preclinical studies (Kwon et al., 2002) and maximise the scientific gain for each completed
trial, the need to design more inclusive trials is particularly pressing (Tuszynski et al., 2006).
However, this can only be sensibly implemented with innovative stratification approaches that
predictively identify homogeneous subgroups of trial participants within a heterogeneous
population and possibly help define reasonable cohort-specific outcomes.
5.1 Current approaches
A historical revision of key studies in spinal cord injury (Lammertse, 2012) reveals that strat-
ification procedures have been either very narrow (Lammertse et al., 2012), or rather broad
(Geisler et al., 2001b; Dobkin et al., 2006; Cardenas et al., 2007), when not basically omitted
(Bracken et al., 1984, 1990, 1997; Geisler et al., 1991). Trial scientists have been heavily rely-
ing on clinical scales for stratifications (Geisler et al., 2001b; Dobkin et al., 2006; Cardenas et
al., 2007), the most common of which is the American Spinal Injury Association Impairment
Scale (Kirshblum et al., 2011). The 5-step scale represents a clinical tool developed to broadly
categorize motor and sensory impairment in individuals who suffered a spinal cord lesion.
Despite their widespread use in the clinical setting, the grades of the Impairment Scale have
been repeatedly proven neither to be a valuable measure for endpoint definition (Geisler et al.,
2001b; Lammertse et al., 2012; Steeves et al., 2006) nor to suffice as a fine-grained stratification
as required by clinical trials (Velstra et al., 2014; Tanadini et al., 2015).
More recently, other researchers attempted to create clinical algorithms for the prediction of
long-term outcomes and for patient stratification (Zo¨rner et al., 2010; van Middendorp et al.,
2011; Wilson et al., 2012). Nonetheless, their approaches were developed with regard to very
specific functional outcomes. In addition, by relying on the statistical modelling techniques
of multiple linear and logistic regressions, they left the identification of more homogeneous
subgroups for participants with varying degrees of lesions unanswered.
5.2 Unbiased recursive partitioning by conditional inference
To overcome previous limitations and address both the need for inclusive trials but also the ne-
cessity of stratification of a heterogeneous spinal cord patient population, we adopted for the
first time in the field the approach of recursive partitioning by conditional inference (Hothorn
et al., 2006). Tree-based regression models of this type are in fact specifically designed and
particularly useful for screening heterogeneous populations to identify more homogeneous
patient subgroups.
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Generally speaking, the recursive partitioning algorithm is a tree-structured regression model
based on sequential tests of independence, sequentially producing binary splits into the ini-
tially heterogeneous population to produce disjoint and more and more homogeneous pairs
of subgroups (see Figure 2).
Figure 2.: A clinical application of unbiased recursive partitioning by conditional inference (Figure 1A
from Velstra et al. (2014)). In an attempt to predict quantitative grasping [QtG] six months after
spinal cord injury, the algorithm led to a partition of the initial patient population into five patient
subgroups with increasingly positive outcomes. The splitting procedure is based on the selected
covariates manual muscle testing [MMT], upper extremity motor score [UEMS], and quantitative
grasping [QtG] measured at baseline.
The algorithm is based on two fundamental steps:
1. Test of independence between endpoint and covariates, followed by variable selection
The statistical association of each possible covariate–endpoint pair is computed and a
multiple-testing corrected p-value is assigned. If the global null hypothesis of total in-
dependence between covariates and outcome cannot be rejected, the algorithm stops
without producing any split. Conversely, when at least one covariate is significantly
associated with the clinical endpoint, then the algorithm selects the covariate with the
strongest statistical association. The variable selected, as well as the p-value of its asso-
ciation with the outcome are reported in the inner nodes (circles in Figure 2).
2. Splitting procedure
The algorithm evaluates all possible dichotomous splits on the covariate selected. The
split is eventually set so as to maximize the discrepancy between the newly formed
subgroups, making the subgroups as different as possible with regard to the endpoint
selected. The best binary split is reported on the lines connecting nodes (see Figure 2).
3. Recursive repetition
As long as the algorithm can identify covariates which are significantly associated to the
endpoint, the previous steps of variable selection and splitting procedure are repeated in
an iterative manner. When the algorithm stops, the outcome distribution in the terminal
nodes is represented graphically (boxplots in Figure 2).
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In contrast to other implementations of recursive partitioning, the separation of variable se-
lection and splitting procedure prevents the systematic tendency towards covariate selection
with many possible splits, independently of their association with the response (Hothorn et
al., 2006). In addition, it also permits the implementation of statistically motivated stopping
criteria (Hothorn et al., 2006). Recursive partitioning by conditional inference leans itself on
a general recursive binary partitioning algorithm, but constructs independence tests under a
permutation testing framework based on conditional distribution developed by Strasser and
Weber (1999). Unbiased recursive partitioning by conditional inference is implemented by the
function ctree of the add-on package party in the R system for statistical computing.
5.3 Advantages of the chosen approach
The application of unbiased recursive partitioning by conditional inference in the setting of
spinal cord injury makes it possible to define relevant subgroups of patients at an early stage
of a trial. This is easily achieved by training the regression model using covariates that corre-
spond to clinical assessments performed shortly after injury. Consequently, as soon as baseline
characteristics of patients are defined, data-driven, objective decision rules can be easily im-
plemented to assess subgroup belonging and predicted recovery.
Subgroups defined by the algorithm can be applied both at the outset of a trial to define in-
clusion/exclusion criteria. In some instances, it may be advantageous to exclude a subgroup
of subjects because their predicted spontaneous recovery is so minimal that even an effective
treatment would not be detectable. On the other end of the spectrum, a subgroup of partic-
ipants may be excluded because their predicted recovery is so extensive that ceiling effects
would become a serious issue. The algorithm allows therefore a targeted enrolment of partic-
ipants that not only are likely to respond to a treatment, but also where the treatment effect is
likely to be detected.
For those participants who are included into the trial, the trial planner may resort to the
partitioning model that already defined a stratification scheme. If the analyses are to be con-
ducted strata-wise, our approach also offers clinicians with the option to define different,
strata-specific endpoints before the study begins. Especially when considering activity-based
endpoints, which are requested for confirmatory phase III trials, the definition of success-
ful treatment effect may vary considerably among subgroups of participants with different
baseline characteristics and different predicted recovery.
This new ability of being able to use broad inclusion criteria allows to efficiently allocate the
few available participants (Wyndaele and Wyndaele, 2006), and at the same time define patient
subpopulations which reduce the heterogeneity of spontaneous recovery patterns (Fawcett et
al., 2006). This peculiarity of the proposed approach is likely to prevent distortion of trial
results due to a small number of participants exhibiting uncommon recovery patterns, as
well as the detailed investigation of subtle treatment effects in more homogeneous subgroups.
Undoubtedly, in addition to the exclusion of patient subgroups, a number of other criteria
influences the final number of participants enrolled into a trial (the “funnel effect” in Jones
et al. (2010)). Nonetheless, the potential inclusion of a large percentage of participants with
different lesions combined with the a priori identification of more homogeneous subgroups
represents a clear improvement in trial design.
Compared to clinical algorithms for the prediction of long-term outcomes and for patient
stratification (Zo¨rner et al., 2010; van Middendorp et al., 2011; Wilson et al., 2012) our approach
further provides a number of more technical advantages. Contrary to linear and logistic re-
gression, unbiased recursive partitioning does not assume linear effects of the covariate (on
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the link scale) and considers automatically interactions among covariates, providing a more
flexible regression framework than usually applied in clinical research. In addition, the central
step of variable selection is carried out on the p-value scale. The p-values for the test statistics
can be directly compared, even if the covariates themselves are measured on different scales,
which is a very likely scenario for all clinical settings. While linear or logistic regressions
usually enforce a complete-case analysis with sometimes drastic consequences for the sample
size, unbiased recursive partitioning prevents such large loss of data by momentarily exclud-
ing missing values in specific covariates during variable selection, but allowing measurements
of a subject on all other covariates for the same algorithm step. In addition, our approach de-
livers a visualisation of the endpoint distribution of each identified subgroup, allowing a more
direct examination and clinical validation of the obtained partitioning, as well as a visual aid
to the formulation of possible subgroup-specific endpoints. More importantly, though, only
unbiased recursive partitioning provides data-driven criteria for the identification of more ho-
mogeneous subgroups. Even the best-performing linear and logistic regression model leaves
ultimately to the clinician the decision on where to draw the line for patient stratification,
contributing therefore little to the main problem introduced by the necessity to design more
inclusive trials.
6 Analysing a study: models for multiple-item rating scales
Endpoints generated by multiple-item rating scales are ubiquitous in neurological disciplines,
and often represent the only data format which clinical assessments provide (Hobart, 2003).
This is alike in the field of spinal cord injury, where most of motor, sensory, and functional
outcomes are of this type (Catz et al., 2007; Kirshblum et al., 2011; Kalsi-Ryan et al., 2012). The
advent of Patient Reported Outcomes will further confront trial scientists with multiple-item
rating scale outcomes. Nonetheless, despite the ubiquity of multiple-item rating scales used to
measure health outcomes in patients with neurological disorders, current analysis approaches
represent a major weakness of the translational process (Hobart et al., 2007). In fact, ordinal
scales are characterized by arbitrary numerical scores establishing a ranking of observations,
where the difference between two following ranks is by no means bound to be equivalent
across the entire item range. In addition, many neurological rating scales comprise items
adressing and measuring several health domains. Therefore, the calculation of total summed
scores and the use of statistical methods developed for continuous endpoints are questionable.
6.1 Current approaches
A historical revision of key studies in spinal cord injury (Lammertse, 2012) reveals that
multiple-item rating scales are consistently analysed as a single overall summed score (or
difference of total summed scores between baseline and follow-up) (Bracken et al., 1984, 1990;
Geisler et al., 1991; Bracken et al., 1997; Cardenas et al., 2007). Nevertheless, those approaches
have been shown to be inappropriate with regard to several aspects (Agresti, 2010), and con-
sequences such as biased parameter estimates, misleading associations and loss of power are
some of the known consequences of assuming metric properties for ordinal endpoints (Win-
ship and Mare, 1984; Hastie et al., 1989; Scott et al., 1997).
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6.2 Proportional odds model
To overcome previous limitations in the analysis of multiple-item rating scales such as the
Upper Extremity Motor Scores (UEMS) in a classical two-armed randomized clinical trial, we
proposed an autoregressive transitional ordinal model. The model is essentially a proportional
odds regression model that includes baseline motor scores, a factor denoting the lesion level
and the distance from it, an autoregressive term and a treatment indicator as explanatory
variables.
The transitional ordinal model derives its name from the fact that this model analyses out-
comes while controlling for the score obtained at the baseline assessment. The baseline motor
scores are often included in trial analyses for baseline adjustment (Bracken et al., 1997; Carde-
nas et al., 2007), but their ordinality is discarded. The chosen modelling strategy is particularly
useful in our setting: even in the case when the outcome distributions in the two trial arms
were identical, the difference between baseline and end-of-trial assessment (the transition) may
very well differ (Agresti, 2010).
The second term of the model codes for motor lesion level and the distance from it. The
motor lesion level is introduced to ensure that only key muscles that have been affected by
the injury, and on which an improvement of motor function can be actually recorded, are
included into the analysis. Basically, the motor lesion level is defined as the most caudal
key muscle with normal motor function. By definition, key muscles above the motor level
have a maximal score on the rating scale. Since the vast majority of patients who suffered a
spinal cord injury show a certain degree of recovery, the analysis of key muscles above the
lesions is not sensible as they already have the maximal score. A further improvement, either
due to spontaneous recovery or a treatment effect, cannot be recorded due to ceiling effects.
Therefore, we analysed only key muscles below the motor level. Those key muscles have been
affected by the injury, and any improvement of motor function can be readily recorded. In
addition, we also coded for the distance of the key muscle being analysed to the motor level.
This introduces a relabelling of the key muscles depending on their relative distance from
the injury rather that their absolute position along the spinal cord, putting therefore all the
affected key muscles on a common footing prior to analysis.
The autoregressive term of the model describes the anatomical structure of the spinal cord,
and reproduces the decreasing pattern of motor scores with increasing distance from the
motor level. Specifically, this term postulates that the motor score of a given key muscle
depends explicitly on the motor score of the key muscle just rostral to it.
This formulation of the proposed transitional ordinal model includes both the most relevant
prognostic factors such as baseline motor scores and motor lesion level, but also introduces a
key muscle relabelling and interdependence derived from anatomical considerations.
Model fitting is implemented by the function polr of the add-on package MASS in the R
system for statistical computing.
6.3 Latent variable model
Latent variable methods are successfully applied in situations where the variable of major
interest cannot be measured directly, and must be inferred from a set of observed variables
called indicators (Bartholomew et al., 2008). A common illustrative example regards to the
study of human intelligence: as this concept cannot be measured directly, psychologists collect
information in the form of examination questions. The examination questions not only can
be easily measured, but are also related to, or are an indicator of, the underlying concept of
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interest (Everitt and Hothorn, 2011). The same logic applies to most primary endpoints in
spinal cord injury: the key variable, which cannot be measured directly, is the neurological
status of a patient. Instead, other measurable variables such as the Upper Extremity Motor
Scores should be thought as a collection of indicators used to make inference about the latent
variable of interest. This concept is rendered graphically as a path diagram in Figure 3.
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Figure 3.: Simplified path diagram representing the dependencies among key muscles as indicators
(boxes), and the latent variable neurological status (circle).
In a setting where all indicators are measured on rating scales, and the latent variable inferred
is metrical, the techniques are collectively referred to as Latent Trait Analysis (LTA). LTA relies
on the assumption that, given the latent variabels, the indicators are independent from each
other, or vice versa the correlations observed among the indicators are due to their relationship
with a common latent trait. Under this postulate, Maximum Likelihood methods exist that
choose the parameter values wich make the outcome frequency distribution predicted by the
model as close as possible to the one observed in the data.
LTA models put the analysis of multiple-item rating scale on a much more rigorous and so-
phisticated inferential framework. It allows in fact to formally test the two major implicit
assumptions of currently used analysis approaches, namely unit change and unidimensional-
ity of the multiple-item rating scale. Firstly, a nominal LTA can shed light onto the validity of
summing all motor scores in an unweighted total score. If all standardized loadings were of
similar magnitude, this would imply a similar discriminating power of all items. As a simi-
lar weight would be applied to each response, the individual scores on the latent dimension
would give a similar ranking as the total summed scores (Bartholomew et al., 2008). Secondly,
an ordinal LTA performed at single time points assesses whether all items or key muscles are
indicators of a single, unidimensional latent health domain. This feature is tacitly assumed
in current analysis approaches, but, to our knowledge, has never been tested formally. The
dimensionality on a measuring instrument is assessed by fitting LTA models with increasing
latent dimensions, which are then compared in terms of model fit to determine how many
latent variables are necessary to best reproduce the observed data.
In addition, the longitudinal evolution of UEMS can also be modelled within the framework
of latent variables. This essentially is achieved by adding an additional layer on top of the
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LTA models. The first layer models the key muscles at each time point as indicators of the
latent neurological status. The repeated measurement of the latent neurological status are
thus themselves taken as indicators for so-called latent growth factors describing the intercept
and slope components of the trajectory modelled (see Figure 4).
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Figure 4.: Simplified path diagram representing the dependencies among the key muscles as indicators
(boxes at the top), the latent variable neurological status at each time point (circles in the middle),
which are themselves used as indicators of further latent variabels describing the intercept and
slope component of the longitudinal growth modelling (circles at the bottom).
In a classical regression fashion, baseline covariates were allowed to directly influence both
the intercept and slope components. In future studies, an indicator for treatment arm can be
added in a straightforward manner, providing a test for treatment effect in the longitudinal
analysis of neurological endpoints.
In the field of spinal cord injury, latent variable models of this type have been successfully
used to investigate psychological traits (McColl et al., 2003; Cruz-Almeida et al., 2005; Martz
et al., 2005; Krause et al., 2009; deRoon Cassini et al., 2010; Catalano et al., 2011; Bonanno et al.,
2012). Despite the similarity in scientific terms, to our knowledge, we are the first to apply
the same methodology to a neurological endpoint, highlighting the shortcomings of currently
adopted approaches.
Latent variable models are implemented in the statistical modeling program Mplus.
7 Advantages of the chosen approach
For the first time in spinal cord injury, the analysis of the multiple-item rating scale of the
Upper Extremity Motor Scores is carried out within an ordinal regression approach, putting
its analysis on a much more appropriate and sophisticated framework. In fact, our approach
prevents the known consequences of assuming continuous properties for summed multiple-
item rating scores (Winship and Mare, 1984; Hastie et al., 1989; Scott et al., 1997; Agresti, 2010),
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which is the current approach in the field.
The proposed transitional ordinal model analyses a sensible subset of key muscles (below
the injury level), focusing therefore on those key muscles that were actually impacted by
the lesion and can achieve a measurable recovery during rehabilitation. By including all the
most relevant prognostic factors and a direct dependency on scores of adjacent key muscles,
reproducing therefore the observed pattern of lower motor scores with increasing distance
from the lesion, additional care is taken to make sure that the model is reflective of clinical
and biological aspects of spinal cord anatomy and lesion severity.
The parameter that quantifies the treatment effect can be interpreted as a conditional odds
ratio. In contrast to a clinically intangible improvement on mean motor scores provided by
current approaches, odds ratios are a common and accepted way of quantifying treatment
effect in the clinical setting and can be readily visualised in easily interpretable bar plots.
Even in the case when the proportional odds assumption is not fully met, it still provides a
meaningful summary of global treatment efficacy (Scott et al., 1997).
Expanding on the important improvement provided by the proportional odds model, we pro-
posed a strategy for the modelling of the longitudinal evolution of Upper Extremity Motor
Scores. In essence, the latent variable model is a generalisation to more than two response
categories of the standard logistic model for binary data, and is closely related to the pro-
portional odds model. This approach is based on a statistical framework designed to model
rating data with the specific structure of the longitudinal neurological score represented by
UEMS. Not only is the ordinality of the data maintained, the approach also addresses in a
formal way the assumptions of metric properties and dimensionality of current analysis ap-
proaches for spinal cord-specific multiple-item rating scales with the potential to invalidate
analyses. Its flexibility further allows to incorporate an indicator for trial arm, providing a
test for treatment effect in the longitudinal analysis of neurological endpoints.
Although the mathematical foundation of latent variable models is quite challenging (Hobart
et al., 2007), they have the potential to change the face of endpoint analysis in all health
domains confronted with multiple-item rating scales (Hobart, 2003) by placing them within a
much more rigorous and sophisticated inferential framework.
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8 Outlook
Despite a much improved understanding of the mechanisms of neuronal plasticity and regen-
eration, clinical trials in neurological diseases are among the most challenging to conduct. In
fact, a historical review of conducted spinal cord injury trials reveals that the majority of them
did not succeed. As a consequence, there is still not an approved treatment for improving neu-
rological function nor a consensus standard of care specific to people who suffered a spinal
cord injury. The promises of preclinical discoveries have yet to be translated into treatments
safely applicable to humans.
While the failure of any particular clinical trial can be imputed to a number of concomitant
reasons, the poor choice of primary endpoints and their analysis as well as the large het-
erogeneity of few potential patients represent the hallmark of neurological trials. This thesis
tackles both issues of patient inclusion and endpoint analysis, and proposes an innovative
approach for the reliable stratification of homogeneous participant subgroups within a het-
erogeneous neurological disorder, as well as develops and tailors statistical methods used to
analyse complex ordinal endpoints generated by multiple-item rating scales.
These new approaches and principles for decision-making in the clinical setting are an es-
sential, yet previously missing component and will extend the current guidance concerning
the conception of clinical trials. The latter had been condensed in four publications by the
International Campaign for Cures of Spinal Cord Injury Paralysis, which touched on many
crucial aspects such as trial design, inclusion and exclusion criteria, and clinical trial end-
points, but nonetheless in a rather descriptive nature. Our results provide indeed specific
solutions for the planning of future clinical trials by providing data-driven decision rules for
patient stratification and inclusion/exclusion as well as for the analysis of complex ordinal
endpoints collected in spinal cord injury. At the same time, all the approaches presented are
very flexible: the methodology can be applied to any particular set of clinical variables and
patient population, and are therefore intended to act as a template across medical disciplines.
We are confident that the proposed approaches are going to be more and more applied in
spinal cord injury and related disciplines, where the awareness of current limitations in the
planning and analysis of trials has been rising. In this context, I think that future work and
research will move on two parallel tracks.
On the one hand, clinicians and trial scientists will be confronted with the process of under-
standing, getting comfortable with, and finally adopting the proposed or similar approaches.
Admittedly, the mathematical foundations and terminology of those methods can be quite
challenging for researchers and clinicians with limited exposure to statistics. Nonetheless,
those methods provide a huge potential to change the face of health outcomes by placing
the analysis of complex ordinal endpoints within a much more rigorous and sophisticated
inferential framework. I personally think that clinicians should strive to develop an under-
standing for those statistical methods, without delving into their mathematical foundations.
Being able to use the methods to best serve their patients and research interests should be
the goal to aim to, trusting the more technical issues to the method developers. The same
approach is employed in the clinical setting for a number of other techniques routinely em-
ployed in hospitals such as rehabilitation robots and magnetic resonance imaging. While
being very complex techniques, the accessibility (and not a detailed understanding) to the
medical staff was one key element for their wide dissemination. In this sense, the diffusion
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of such approaches could probably be greatly enhanced by developing and distributing some
kind of down-loadable applications for smart phone and similar, as it has happened for many
health and lifestyle monitoring devices. Being able to quickly and easily visualize several
stratification scenarios with a few screen touches will greatly increase the attractiveness of the
proposed approaches. To my knowledge, some effort in this direction is already underway.
On the other hand, statisticians will probably be looking at the combination of latent variables
modeling strategies with recursive partitioning by conditional inference. In fact, our results
clearly suggest that unbiased recursive partitioning is a very promising way to facilitate the
design of more inclusive clinical trials. At the same time though, we reported clear evidence
that the commonly adopted Motor Scores endpoint should not be analyses as a total sum of
scores, but rather analysed within the framework of latent variable models, where each key
muscle represent an indicator for a common underlaying health domain. I would therefore
anticipate that more advanced approaches will first convert the Motor Scores into the corre-
sponding position of a given patient on the latent variable, and subsequently this information
will be fed into the recursive partitioning framework to obtain a partition of participants based
on their latent neurological status. This approach could take advantage of both themes cov-
ered in this thesis and achieve a better patient stratification scheme preventing any inferential
issues based on the inherent limitations of rating scales.
Future work and research on these two parallel tracks will be very important for the promo-
tion of advanced and especially more appropriate statistics in the clinical field. A continuous
exchange between statisticians and clinical scientists is going to be the key for a fruitful and
successful interdisciplinary research stream delivering statistically improved approaches rep-
resenting tailored clinical solutions. Ultimately, the ambition of all people involved and the
results published within the framework of this thesis are intended to fast-forward the clinical
process leading to specific therapeutic treatments for people living with spinal cord injury.
We are glad that our proposed approaches are already being considered and employed in the
planning and analysis of clinical trials!
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Thesis Summary
This thesis consists of four papers. In pairs, the four projects address two major peculiarities
of spinal cord injury trials, namely the high variability of the small patient population, and
the analysis of neurological endpoints delivered by multiple-item rating scales. Both aspects
are leading causes of the lagging translational process and require the application of more
appropriate and innovative statistical methods.
Paper I and Paper II focus on the reliable stratification of homogeneous subgroups and the
prediction of future clinical outcomes within a heterogeneous neurological disorder such as
spinal cord injury. Paper I employed for the first time in the field the unbiased recursive
partitioning technique called conditional inference tree, which is a tree-structured regression
model based on sequential tests of independence specifically designed to identify more ho-
mogeneous subgroups within an initial heterogeneous patient population. Paper II provides
a further application of unbiased recursive partitioning to a commonly targeted and clinically
relevant population of participants to facilitate the design of more inclusive clinical trials. The
comprehensive analyses provide a flexible template to help design future clinical studies.
Paper III and Paper IV address current limitations in the statistical analysis of neurological
endpoints in the form of complex ordinal outcomes. In Paper III, we propose a transitional
ordinal model with an autoregressive component in a common spinal cord trial setting. Paper
IV discusses limitations of neurological rating scales and their longitudinal analysis within
the unifying framework of latent variable modelling.
The content and contributions of each paper are briefly summarized below.
Paper I
Identifying Homogeneous Subgroups in Neurological Disorders: Unbiased Recursive Parti-
tioning in Cervical Complete Spinal Cord Injury by Lorenzo G. Tanadini, John D. Steeves,
Torsten Hothorn, Rainer Abel, Doris Maier, Martin Schubert, Norbert Weidner, Ru¨diger Rupp,
Armin Curt
The necessity to develop a strategy permitting the enrolment of participants with varying de-
grees of injuries to compensate for the limited pool of available patients (Sekhon and Fehlings,
2001), but also to maximise the scientific gain of knowledge for each completed trial can only
be sensibly achieved with the capability to implement a stratification procedure to limit subject
heterogeneity within study cohorts (Marino et al., 1999; Tuszynski et al., 2006).
This paper reports the first application of recursive partitioning by conditional inference
(Hothorn et al., 2006), a tree-based regression models specifically designed for screening het-
erogeneous populations and identifying more homogeneous subgroups. The paper introduces
the model, and compares it to commonly adopted linear and logistic regression techniques
(Zo¨rner et al., 2010; van Middendorp et al., 2011; Wilson et al., 2012). While confirming simi-
lar prediction accuracy for all approaches, a retrospective analysis of prospectively collected
neurological data revealed the advantages of data-driven and easily implementable rational
for early patient stratification provided by recursive partitioning.
The clinical setting and the necessity of reliable stratification of homogeneous cohorts were
outlined by Prof. Curt and Prof. Steeves. The specific statistical approach of unbiased recur-
sive partitioning by conditional inference was suggested by Prof. Hothorn. Data preparation,
initial inference, as well as final analyses and the writing of the manuscript were done by
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myself. Prof. Hothorn, Prof. Steeves, and Prof. Curt reviewed the manuscript at several stages
and contributed to improve it. The remaining co-authors are members of the European Mul-
ticenter Study about Spinal Cord Injury, which collected and granted access to the data. They
read and approved the final version of the paper. The period of my thesis in which this paper
was produced was financially supported by the the International Foundation for Research in
Paraplegia.
The main contribution of this paper is the context-specific presentation of a flexible approach
for early patients stratification easily adaptable to future clinical studies confronted with small
and/or heterogeneous patient populations.
Paper II
Toward Inclusive Trial Protocols in Heterogeneous Neurological Disorders: Prediction-Based
Stratification of Participants With Incomplete Cervical Spinal Cord Injury Lorenzo G. Tana-
dini, Torsten Hothorn, Linda A. T. Jones, Daniel P. Lammertse, Rainer Abel, Doris Maier,
Ru¨diger Rupp, Norbert Weidner, Armin Curt, John D. Steeves
Building upon the results achieved in Paper I, this paper discusses the application of con-
ditional inference trees on the clinically relevant group of patients with incomplete spinal
cord injury. The inclusion of participants with incomplete lesions is justified, as many of the
experimental approaches under scrutiny were developed using animal models with incom-
plete lesions. Given their spared function, it is also expected that patients with incomplete
spinal cord injury are more likely to benefit from therapeutic interventions (Tuszynski et al.,
2006). However, the incomplete injury population is highly heterogeneous in terms of level
and severity of injury, which gives rise to a diversity of recovery patterns (Marino et al., 1999;
Geisler et al., 2001a; Fawcett et al., 2006).
The paper applies conditional inference trees (Hothorn et al., 2006) to a real-world trial setting
based on retrospectively analysed, but prospectively collected neurological data, generating
decision rules for the appropriate inclusion of participants. The prediction-based stratifica-
tion of subjects with an incomplete lesion paves the way to a broad, but controlled inclusion
and stratification of participants from a heterogeneous patient population. The algorithm also
supports the selection of specific endpoints for each stratified cohort. The conditional infer-
ence tree produced was validated both internally as well as externally, providing stable and
generalisable results.
The clinical setting and the research question were proposed by Prof. Curt and Prof. Steeves.
The statistical approach of unbiased recursive partitioning was suggested by Prof. Hothorn.
Data preparation, initial inference, as well as final analyses and the writing of the manuscript
were done by myself. Prof. Hothorn, Prof. Steeves, Prof. Curt reviewed the manuscript at
several stages and contributed to improve it. The remaining co-authors are members of the
European Multicenter study about Spinal Cord Injury, which collected and granted access to
the data. They read and approved the final version of the paper. The period of my thesis in
which this paper was produced was financially supported by the the International Foundation
for Research in Paraplegia.
The main contribution of this paper is the comprehensive analysis and validation of the clini-
cally highly relevant cohort of incomplete spinal cord injury patients providing a template for
a broad, but controlled inclusion and stratification of participants in future clinical trials.
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Paper III
Autoregressive transitional ordinal model to test for treatment effect in neurological trials
with complex endpoints by Lorenzo G. Tanadini, John D. Steeves, Armin Curt, Torsten Hothorn
Current approaches to the analysis of complex ordinal endpoints generated by multiple-item
rating scales represent a major weakness of the translational process (Hobart, 2003; Hobart et
al., 2007). Although this type of endpoint is ubiquitous in spinal cord injury (Kirshblum et
al., 2011), routinely employed analysis approaches introduce several limitations (see Agresti
(2010) for a general overview) by considering a single overall summed score and assuming it
being a continuous measure (Bracken et al., 1984, 1990; Geisler et al., 1991; Bracken et al., 1997;
Cardenas et al., 2007).
This paper proposes a transitional ordinal model with an autoregressive component to over-
come widespread limitations in the analysis of endpoints in spinal cord injury (Winship and
Mare, 1984; Hastie et al., 1989; Scott et al., 1997; Agresti, 2010; Hobart et al., 2007). The model
was fitted retrospectively to prospectively collected neurological data regarding a relevant
primary endpoint in the field. A large simulation study of two-arm randomised clinical trial
revealed an important gain in statistical power in virtually all simulation settings. A revisita-
tion of a key historical trial (Geisler et al., 1991) provides a head-to-head comparison between
the proposed and currently employed analysis approaches, highlighting drawbacks of the
latter.
The idea to resort to statistical approaches explicitly developed for the analysis of ordinal
endpoints was suggested by Prof. Hothorn. In discussion with Prof. Hothorn, I developed
the final model for the segment-wise analysis of the endpoint, which relies on the analysis of
items (e.g. key muscles) depending on their distance along the spine from the site of injury.
In addition, we included an autoregressive term to account for the anatomical structure of
the spinal cord and the observed pattern of decreasing scores for more caudal segments.
Data preparation, models fitting, implementation of the simulation, analysis of the historical
trial, as well as the writing of the manuscript were done by myself. Prof. Hothorn reviewed
the manuscript at several stages and provided support for the simulation implementation,
Prof. Curt and Prof. Steeves provided inputs to an advanced version of the manuscript. This
paper was partly produced with the financial support of the the International Foundation for
Research in Paraplegia.
The main contribution of this paper is the implementation of an ordinal regression model
which represents a specific solution to the analysis of a complex ordinal endpoint in spinal
cord injury.
Paper IV
Addressing limitations of rating scales and their analysis in spinal cord injury under the unify-
ing framework of latent variable modelling by Lorenzo G. Tanadini, Armin Curt, Irini Mous-
taki
Expanding on the important improvement provided by the ordinal approach, and supported
by the specific structure of the longitudinal neurological data being analysed, we took full ad-
vantage of recent statistical developments in social statistics (Liu and Hedeker, 2006; Cagnone
et al., 2009; Vasdekis et al., 2012), a field where the analysis of repeated ordinal measurements
is common. In fact, modelling multivariate longitudinal ordinal responses based on a latent
- 18 -
variable approach seemed both appealing and appropriate for applications in the spinal cord
setting.
This paper addresses metric properties and dimensionality of a spinal cord-specific multiple-
item rating scale, and proposes an approach for the longitudinal modelling of neurological
recovery following injury. The retrospective analysis of prospectively collected neurological
data revealed that unidimensionality holds only for a subset of initially included patients.
Important simplification in further analysis steps could be substantiated. The longitudinal
modelling reported a strong negative correlation between intercept and slope terms.
I proposed the idea to apply statistical methods developed in the social sciences. In discussion
with Prof. Moustaki, I finalised and implemented the assessment of metric properties and
longitudinal modelling of the neurological endpoint chosen under the unifying framework of
latent variable modelling. Data preparation, exploratory analyses, as well as final analyses and
the writing of the manuscript were done by myself. Prof. Moustaki provided support during
the implementation phase and reviewed the manuscript at several stages. Prof. Curt provided
inputs to an advanced version of the manuscript. This paper was produced at the Department
of Statistics of the London School of Economics, London UK with the financial support of a
Swiss National Science Foundation doctoral mobility fellowship (Project P1ZHP3 158783) and
the Janggen-Po¨hn Foundation, St. Gallen.
The main contribution of this paper is the comprehensive analysis of complex ordinal end-
points entirely based on inferential framework of latent variable modelling.
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Introduction
Traumatic spinal cord injury (SCI) is a heterogeneous disor-
der in terms of pathology, neurological deficits, and subse-
quent spontaneous recovery.1,2 Furthermore, seemingly 
comparable cord injuries (as classified by the American 
Spinal Injury Association [ASIA] Impairment Scale [AIS 
A-E]), can achieve a diverse range of neurological and 
functional recovery, especially after incomplete SCI.3 This 
is similar to other central nervous system disorders and 
makes reliable prediction of future outcomes challenging.
Despite this, the reliable prediction of future clinical end-
points is important to the implementation of targeted care 
and effective treatment options. In addition, reliably defin-
ing relatively homogeneous subgroups for clinical trials is 
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Abstract
Background. The reliable stratification of homogeneous subgroups and the prediction of future clinical outcomes within 
heterogeneous neurological disorders is a particularly challenging task. Nonetheless, it is essential for the implementation 
of targeted care and effective therapeutic interventions. Objective. This study was designed to assess the value of a recently 
developed regression tool from the family of unbiased recursive partitioning methods in comparison to established 
statistical approaches (eg, linear and logistic regression) for predicting clinical endpoints and for prospective patients’ 
stratification for clinical trials. Methods. A retrospective, longitudinal analysis of prospectively collected neurological data 
from the European Multicenter study about Spinal Cord Injury (EMSCI) network was undertaken on C4-C6 cervical 
sensorimotor complete subjects. Predictors were based on a broad set of early (<2 weeks) clinical assessments. Endpoints 
were based on later clinical examinations of upper extremity motor scores and recovery of motor levels, at 6 and 12 
months, respectively. Prediction accuracy for each statistical analysis was quantified by resampling techniques. Results. For 
all settings, overlapping confidence intervals indicated similar prediction accuracy of unbiased recursive partitioning to 
established statistical approaches. In addition, unbiased recursive partitioning provided a direct way of identification of more 
homogeneous subgroups. The partitioning is carried out in a data-driven manner, independently from a priori decisions 
or predefined thresholds. Conclusion. Unbiased recursive partitioning techniques may improve prediction of future clinical 
endpoints and the planning of future SCI clinical trials by providing easily implementable, data-driven rationales for early 
patient stratification based on simple decision rules and clinical read-outs.
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important to accurately determining whether a therapeutic 
intervention provides a distinct benefit.4-6 In many situa-
tions, such as a study of the biological or functional activity 
of an experimental therapeutic in early phase clinical trials, 
it is desirable to only enroll subjects who are relatively 
homogeneous in terms of both their early neurological sta-
tus, as well as their prognosis for achieving a defined clinical 
endpoint (eg, future outcome). If trial participants have het-
erogeneous neurological and functional characteristics when 
assigned to a study arm, the contribution of a small number 
of participants may distort the overall results, the outcome 
interpretation, and disregard subtle treatment effects, thereby 
wasting subject and study resources.
Recently, in SCI, attempts have been made to create clin-
ical algorithms for the prediction of long-term endpoints 
and for patient stratification.7-9 These algorithms relied on 
the statistical techniques of multiple linear and logistic 
regressions. In this study, we compare these established sta-
tistical regression approaches7-9 with a recently developed 
unbiased recursive partitioning regression tool called 
Conditional Inference Tree (URP-CTREE),10 which directly 
identifies more homogeneous subgroups from an initial het-
erogeneous population. The aim was to compare the predic-
tive accuracy of URP-CTREE against established regression 
models to predict future clinical endpoints from early neu-
rological assessments, and to investigate the contribution of 
these methods to the stratification of cervical sensorimotor 
complete (AIS A) subjects into homogeneous subgroups.
Methods
Data Source
Data were obtained from the European Multicenter study 
on Spinal Cord Injury (EMSCI; http://www.emsci.org); an 
ongoing European network of SCI centers prospectively 
gathering data from subjects over the first year after trau-
matic SCI. The standardized assessment protocol tracks the 
neurological and functional status of patients during recov-
ery from SCI. The EMSCI database was established in 2001 
and has collected data from more than 2500 subjects during 
the past 12 years from 21 centers in 7 European countries.
Inclusion Criteria
The target population for this study included those EMSCI 
subjects who had cervical sensorimotor complete (AIS A) 
SCI with a Motor Level (from the right body side) at either 
C4, C5, or C6 as determined by a baseline assessment using 
the International Standards for Neurological Classification 
of Spinal Cord Injury (ISNCSCI)11 within the first 2 weeks 
after SCI (Figure 1). Only subjects with a documented 
assessment and determination of the selected clinical out-
come of interest at that endpoint were included.
Two separate analyses are reported. The first analysis 
evaluated the total bilateral Upper Extremity Motor Score 
(UEMS) at 6 months after cervical complete SCI and is 
referred to hereafter as Total-UEMS. ISNCSCI motor score 
is determined by assigning to one muscle group, innervated 
and primarily identified with a specific spinal level, an inte-
ger between 0 (no detectable contraction) and 5 (active 
movement and a full range of movement against maximum 
resistance). Between C5 and T1 there are 5 representative 
“key” arm and hand muscles tested on each side of the body 
for a total upper extremity motor score of 25 + 25 = 50. The 
second analysis examined whether the subject achieved a 
2-motor level improvement within the cervical cord (on 
either the left or right side) by 12 months after cervical com-
plete SCI and is referred to as 2-motor level change. Subjects 
with a cervical complete SCI between C1 and C3 or C7 and 
T1 were excluded from analyses, as it is challenging to track 
the recovery of upper extremity motor scores or there were 
an insufficient number of subjects for statistical analysis.
Predictors and Clinical Endpoints
Potential clinical predictors (early ISNCSCI scores) and 
clinical endpoints (Total-UEMS and 2-motor level change 
at 6 and 12 months after SCI) were selected based on pub-
lished literature12-13 and clinical research experience of the 
authors. The set of predictors characterize the neurological 
status of the subjects according to the criteria of the 
ISNCSCI examination,11 which is routinely assessed at all 
EMSCI specialized SCI care facilities within the first 2 
weeks after injury (mean ± SD = 8.1 ± 4.7 days after injury). 
All predictors were collected according to EMSCI and 
ISNCSCI guidelines. Included predictors were age, the 
motor level (right body side), the bilateral sensory scores 
(light touch, pin prick), and motor scores (upper and lower 
extremity motor score), as well as information on the left 
Figure 1. Subject numbers and selection criteria as extracted 
from the EMSCI database.
Abbreviations: EMSCI, European Multicenter study about Spinal Cord 
Injury; UEMS, Upper Extremity Motor Score; AIS, American Spinal Injury 
Association (ASIA) Impairment Scale.
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and right side for motor and sensory zone of partial preser-
vation (ZPP) below the respective motor or sensory level. 
The zone of partial preservation refers to those segments 
caudal to the motor or sensory levels where there is some 
preservation of impaired motor or sensory function.
Here, we present 2 analyses based on complementary 
clinical endpoints. These endpoints have been related to 
determining changes in both neurological impairment and/
or functional recovery (eg, independence in activities of 
daily living), as well as being suggested as possible clinical 
outcome measures for acute and/or subacute clinical studies 
involving cervical sensorimotor complete (AIS A) sub-
jects.14-16 Ancillary analysis for the bilateral total-UEMS at 
12 months and the 2-motor level improvement within the 
cervical cord (on either the left or right side) by 6 months 
after cervical complete SCI were also performed.
Unbiased Recursive Partitioning: Conditional 
Inference Trees
The unbiased recursive partitioning technique called condi-
tional inference tree (URP-CTREE) is a tree-structured 
regression model based on sequential tests of independence 
between predictors (eg, early clinical characteristics) and a 
specified clinical endpoint (ie, future outcome).10 URP-
CTREE divides an initial heterogeneous population into 
successively disjoint and more homogeneous pairs of sub-
groups with regard to the clinical endpoint of interest, and 
thus creates an algorithm for predicting future outcomes 
within more homogeneous subgroups.
URP-CTREE is based on 2 fundamental steps, which are 
repeated iteratively for each successive split of the initial 
heterogeneous population:
Step 1: Association of early predictors (subject’s charac-
teristics) with the clinical endpoint (outcome). The 
algorithm assesses whether any early predictor is sta-
tistically associated with the selected clinical end-
point. This is performed by individually calculating 
the statistical association of each possible predictor–
endpoint pair (no data are presumed to be normally 
distributed). To each association, a multiple-testing 
corrected P value is assigned (ie, Bonferroni correc-
tion). If the initial null hypothesis of total indepen-
dence between predictors and outcome cannot be 
rejected (no statistically significant association 
between any early predictor and the endpoint), the 
algorithm stops without producing any split of the ini-
tial population. On the contrary, if the null hypothesis 
of independence can be rejected, meaning that at least 
one early predictor is significantly associated with the 
subsequent clinical endpoint, then the algorithm 
selects the predictor with the strongest statistical 
association (smallest P value) and passes it to step 2.
Step 2: Splitting procedure for defining more homoge-
neous pairs of subgroups. Once the most significant 
predictor has been selected (as expressed in step 1), 
the algorithm evaluates all possible dichotomous 
splits on this variable, each one inevitably producing 
2 subgroups. The goodness of each split is evaluated 
by a two-sample linear statistic (eg, χ2 statistic for a 
binary outcome), to maximize the discrepancy 
between the newly formed subgroups. This partitions 
the initial population into 2 subgroups that are as dis-
tinct as possible.
Iterative steps: Recursively proceed to identify any addi-
tional early characteristics (predictors) that signifi-
cantly predict the selected clinical endpoint. The 
recursive part of the algorithm starts over and the 2 
fundamental steps (steps 1 and 2 listed above) are 
repeated separately for 2 newly formed subgroups. 
The URP-CTREE calculations proceed until no more 
statistically significant predictors are associated with 
the selected endpoint (null hypothesis cannot be 
rejected).
Once the clinical endpoint and predictors are selected, 
the algorithm will determine any significant associations 
without allowing any further input or bias by the investiga-
tor. Conditional inference trees can be applied to all types of 
regression problems, and has already been successfully 
used in other clinical settings with heterogeneous patient 
populations, like genetic marker–tumor association 
studies.17,18
Comparison of Statistical Methods
The recently developed URP-CTREE method is considered 
to directly identify more homogeneous study subgroups; 
however, its predictive accuracy needs to be compared 
against established statistical methods. Given the more con-
tinuous nature of the Total-UEMS endpoint, we compared 
multiple linear regressions, Least Absolute Shrinkage and 
Selection Operator (LASSO19) with URP-CTREE. Given 
the binary nature of the endpoint for a 2-motor level change, 
we compared multiple logistic regressions and LASSO with 
URP-CTREE. Linear and logistic regressions are well-
known statistical techniques that have been previously 
employed in SCI research.7-9 For the purpose of this article, 
LASSO can be interpreted as a multiple regression model 
with built-in variable selection.19
For evaluating the accuracy of Total-UEMS prediction, the 
models were compared by computing root mean square error 
(RMSE). RMSE is a frequently used measure of difference 
between observed values and values predicted by a model. It is 
defined as the root of the squared sum of differences between 
observed and predicted value divided by the total sample 
size.20 The URP-CTREE–based prediction for continuous 
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outcomes is computed as the final node–specific mean. For 
assessing the accuracy of 2-motor level change prediction, the 
models were compared by computing the misclassification 
rate. Misclassification rate for a binary outcome is defined as 
the percentage of incorrect future outcome prediction based on 
the model, compared with the actually observed values.20 The 
URP-CTREE–based prediction for binary outcomes is based 
on the final node–specific most likely outcome.
Following standard benchmarking procedures,21 both 
measures were based on 500 bootstrap iterations. All analy-
ses were performed in the computing environment R,22 ver-
sion 2.14.0, and based on the package party: A Laboratory 
for Recursive Partitioning.23
Results
Comparison of Statistical Methods for Predicting 
Clinical Endpoints
The prediction accuracy (RMSE) of Total-UEMS at 6 
months after SCI is based on 500 bootstrap iterations and 
shown in Table 1. All 3 statistical approaches provide simi-
lar median and overlapping 95% confidence intervals (CIs) 
for RMSE.
Likewise, the examined statistical methods for predicting 
a 2-motor level change on either side of the cervical cord 
within the first 12 months after cervical complete (AIS A) 
SCI also provide similar statistical accuracy (Table 2). The 
difference here is the selected clinical endpoint was a binary 
event. Based on 500 bootstrap iterations, Table 2 shows the 
95% CI for misclassification rate. All 3 statistical approaches 
provide similar median and overlapping 95% CI.
Ancillary analyses for Total-UEMS at 12 months and 2-ML 
recovery at 6 months provided similar results in terms of 
median and CI across the different methods. Therefore, for rea-
sons of clarity, this article refers to the primary analysis only.
Direct Identification of More Homogeneous 
Study Subgroups
Figure 2 shows the conditional inference tree (URP-
CTREE) for Total-UEMS at 6 months after cervical senso-
rimotor complete (AIS A) SCI.
In the example shown in Figure 2, the iterative identifica-
tion of more homogeneous subgroups is based on 2 signifi-
cant early neurological predictors, namely UEMS and Motor 
ZPP, as measured within the first 2 weeks after cervical sen-
sorimotor complete SCI. Successive UEMS or ZPP cutoff 
values are indicated at the “branch points” 1, 2, 4, and 7. At 
each branch point, a multiple testing–adjusted P value is 
given, which describes the strength of the statistical associa-
tion between the early predictor (UEMS or ZPP) and the 
endpoint (Total-UEMS). The full distribution of the Total-
UEMS is revealed in the box plots within the final nodes at 
the bottom. The visual representation of a conditional tree is 
directly interpretable and easily applied in a clinical setting 
to determine which subjects to include, exclude, or group 
together for a desired study. Conversely, conventional linear 
regression methods will deliver an equation of the type
Outcome Intercept
Slope Predictor
                  Sl
1 1
= +
+ +…*
ope  Predictorn n∗
which quantifies how predictors are associated with the 
chosen endpoint, but does not provide direct decision rules 
for stratification of subjects into more homogeneous study 
subgroups.
Table 1. Root-mean-squared error as a measure of prediction accuracy for Total-UEMS at 6 months after cervical sensorimotor 
complete (AIS A) SCI. No statistically significant difference in accuracy between the three methods was observed.
Multiple Regression LASSO Recursive Partitioning
95% CI lower bound  7.75  8.25  8.04
Median 11.02 10.41 10.36
95% CI upper bound 17.98 12.63 12.79
Abbreviations: 95% CI, 95% confidence interval.
Table 2. Misclassification rate as a measure of prediction accuracy for 2-motor level change at 12 months after cervical sensorimotor 
complete (AIS A) SCI. No statistically significant difference in accuracy between the three methods was observed.
Logistic Regression LASSO Recursive Partitioning
95% CI lower bound 11.3 14.5 12.5
Median 22.5 26.3 24.4
95% CI upper bound 36.6 38.2 37.7
Abbreviations: 95% CI, 95% confidence interval.
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Figure 3 shows the conditional inference tree (URP-
CTREE) for the 2-motor level change within 12 months 
after cervical complete (AIS A) SCI. The URP-CTREE 
algorithm led to a partition of the initial EMSCI cervical 
AIS A population into 2 subgroups based on UEMS (as 
measured within 2 weeks after injury) and described in the 
final nodes (nodes 2 and 3). A multiple testing–adjusted P 
value is given, which describes the strength of the statistical 
association between the early predictor characteristic 
(UEMS) and the endpoint (2-motor level change). The full 
distribution of the clinical endpoint is revealed within nodes 
2 and 3. Once again, the visual representation of a condi-
tional tree is directly interpretable and can be implemented 
in a clinical setting. Conventional logistic regression meth-
ods deliver equation of the type
Logarithm Prob Prob  Intercept 
Slope Pred
success failure
1
( / )
*
= +
ictor
Slope  Predictor
1
n n
+ +…
*
and do not provide direct decision rules for stratification.
Discussion
Clinical prediction models for the prognosis of potential 
future outcomes as well as for the identification of subgroups 
of SCI patients having predictable recovery patterns are 
essential.1,4,24 Several attempts have been made to create 
clinical algorithms for the prediction of future clinical end-
points and for patient stratification in SCI.7-9 These attempts 
rely on the statistical techniques of multiple linear regres-
sions and logistic regression (for which the following con-
siderations also apply). Despite achieving in some cases 
excellent discrimination in prediction of future clinical end-
points,7,8 these approaches present shortcomings (see Table 
3 for an overview) that may have hindered their wider appli-
cation in SCI. Here, we present unbiased recursive partition-
ing’s conditional inference trees (URP-CTREE) as a 
statistical method that overcomes some of these challenges.
Comparable Prediction Accuracy
In an attempt to overcome some of the drawbacks of estab-
lished regression models, we applied the statistical method 
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Figure 2. Conditional inference tree for the endpoint Total-UEMS at 6 months after cervical sensorimotor complete (AIS A) SCI 
(N=122), using a broad set of neurological and functional predictors assessed within the first two weeks after injury. The upper part 
represents the sequential splits based on early predictors (nodes 1,2,4,7); the lower part represents the achieved partition of the initial 
population into 5 more homogeneous subgroups, as represented by the final nodes (nodes 3, 5, 6, 8, 9). Boxplots at the bottom show 
sample size and distribution of the clinical endpoint within each subgroup (node).
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of conditional inference trees from the family of unbiased 
recursive partitioning methods (URP-CTREE) for the first 
time in SCI. As a first prerogative for its consideration, we 
established that URP-CTREE provides equal statistical 
accuracy in predicting selected clinical endpoints (future 
outcomes) from a broad set of early clinical characteristics 
taken from neurological and functional assessments across 
a sample of cervical sensorimotor complete SCI subjects 
(Tables 1 and 2). In both analyses, median estimates of 
accuracy are similar for all 3 methods tested. Confidence 
intervals based on resampling techniques clearly indicate 
no statistical differences in accuracy across statistical meth-
ods. In general terms, there is no consensus on how to 
define standard reference values for accuracy (eg, correla-
tion coefficient and the differentiation between weak, mod-
erate, and strong); it has to be evaluated depending on the 
specific setting of application.
Drawbacks of Established Regression Methods
Even though linear models are powerful statistical tools 
they may lack specific information that may be essential for 
clinical applications. Multiple linear regression quantifies 
how a given set of early predictors associates with the mean 
of a future clinical endpoint and provides a numeric equa-
tion of these relationships. Linear predictor–outcome rela-
tionships are tacitly assumed and statistical interactions 
rarely modeled (Table 3). Especially in complex neurobio-
logical settings, the assumption of a strictly linear relation-
ship between predictors and clinical outcome, with no 
interactions between predictors do not seem sensible.1,15,16,25 
In addition, focusing on just parameter estimation (eg, the 
mean) prevents an understanding of the full endpoint distri-
bution within a study population (for which the mean is 
only its central tendency).
Even more importantly in the context of clinical trials, 
neither linear nor logistic regression provide a direct and 
objective mean of partitioning an initial, heterogeneous 
population into more homogeneous subgroups, leaving the 
need for stratification unmet. For example, a fitted linear 
regression model provides as a mathematical equation (see 
Results section) quantifying the relationships between pre-
dictors and endpoints. This equation still leaves challenges 
on its implementation in clinical settings, where the han-
dling of such equations cannot be easily implemented to 
inform about the prognosis for an individual subject (Table 
3). In addition, multiple regression showed a higher upper 
bound for the confidence interval (Table 1). This is likely to 
be due to collinearity, a situation which arises when differ-
ent predictors are highly correlated, causing difficulties in 
model fitting and interpretation. Collinearity is an issue in 
established regression techniques, but prevented in URP-
CTREE (and LASSO).
Conditional Inference Trees
In contrast to established regression methods, URP-CTREE 
does not assume linear dependence between predictors and 
endpoint, and it specifically puts the modelling focus on 
interactions between predictors10 (Table 3). In addition, 
URP-CTREE has the major advantage of defining more 
homogeneous subgroups in a direct, data-driven manner 
and to reveal the clinical endpoint distribution within each 
subgroup10 (Table 3). These unique features of URP-
CTREE could be of value for refining the stratification of 
patients for future clinical trials. URP-CTREE could also be 
used as an explorative tool for defining sensible primary 
and secondary outcomes for specific subgroups.
Total-UEMS and 2-Motor Level Analyses
The specific advantages of URP-CTREE outlined above are 
clearly visible in the results provided by the 2 analyses per-
formed. Figure 2 represents the application of URP-CTREE 
to the clinical endpoint of Total-UEMS at 6 months after 
SCI. The occurrence of subsequent splits along the same 
UEMS scale within Figure 2 strongly suggests that it cannot 
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Figure 3. Conditional inference tree for the recovering of at 
least two motor levels (black shading; grey shading indicating 
failure of achieving this specified endpoint) at 12 months 
after cervical sensorimotor complete (AIS A) SCI (N=103), 
using a broad set of neurological and functional predictors 
assessed within the first two weeks after injury. The upper part 
represents the splits based on early predictors (here only node 
1); the lower part represents the achieved partition of the initial 
population into 2 more homogeneous subgroups, as represented 
by the final nodes (nodes 2, 3). Plots at the bottom show sample 
size and distribution of the clinical endpoint for each subgroup.
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be assumed that the recovery between the baseline and 6 
months occurs as a linear function. This is not a new find-
ing1,15,16,25 but stresses the importance of nonlinear effects 
and interactions, which are readily detected by URP-
CTREE.10 However, routine regression analyses tacitly 
assume linearity and usually do not account for interactions. 
Figure 2 also clearly suggests that even within the narrowly 
defined patient subgroups of cervical sensorimotor complete 
(AIS A) there will be variability in recovery, underscoring 
the limited value of an AIS grade both as a stratification tool 
as well as its change as a sensitive measure for any subtle or 
meaningful therapeutic effect.1,16,25 In our sample of senso-
rimotor complete SCI subjects, URP-CTREE also provides 
a way of identifying subjects subgroups that will potentially 
show flooring (Figure 2, node 3) and ceiling (Figure 2, node 
9) effects, which is of great relevance for the planning of 
clinical trials and the definition of primary endpoints.
Figure 3 represents the application of URP-CTREE to a 
binary clinical endpoint, 2-motor level change within 1 year 
after injury. The analysis suggests that cervical AIS A sub-
jects with initial UEMS less or equal 20 (node 2, Figure 3) 
have a much lower probability of spontaneous recovery of 
at least 2 motor levels than subjects with a higher initial 
UEMS (node 3, Figure 3). URP-CTREE shows that select-
ing subjects only from node 2 of Figure 3 would provide 
even more homogeneous subgroups than the inclusion of all 
cervical sensorimotor complete subjects,16 which would 
translate in a lower false positive rate for a possible clinical 
study based on such outcome. Nevertheless, the purpose of 
the 2-motor level change analysis was to demonstrate that 
URP-CTREE works for different types of clinical endpoints 
(continuous Total-UEMS and binary 2-motor level change) 
measured at 2 different time points (6 and 12 months after 
injury), and this partitioning within the population of cervi-
cal complete SCI may not always be necessary or preferred. 
In fact, the overall percentage of subjects recovering at least 
2 motor levels within 1 year after injury (32/117; 27%) 
agrees with previous findings,16 and has been suggested as 
a clinically meaningful primary outcome for cervical senso-
rimotor complete (AIS A) SCI population as a whole.
Homogeneous Subgroups
Our results indicates that URP-CTREE, while being spe-
cifically designed to identify more homogeneous subgroups 
within an initially heterogeneous population, does not com-
promise prediction accuracy when compared to established 
statistical regression approaches. Notably, the same conclu-
sion is reached for 2 different clinical endpoints (continuous 
Total-UEMS change and binary 2-motor level change) 
measured at 2 different time points (Figures 2 and 3). 
Ancillary analysis based on Total-UEMS after 12 months 
and 2-motor level change after 6 months provided similar 
results (similar medians and overlapping confidence inter-
vals) and further evidence for our conclusions.
We based our analyses on a sensorimotor-complete SCI 
population, which is clinically usually recognized as a 
rather homogeneous population in the context of SCI. Our 
analyses show that even within the narrowly defined patient 
subgroups of cervical sensorimotor complete (AIS A), there 
will be substantial variability in recovery (Figure 2), sug-
gesting the need for a more differentiated approach. 
Nonetheless, we recognize that the full potential of URP-
CTREE is expected to be realized in even more heteroge-
neous population, for example, individuals living with 
incomplete SCI.
Choosing Endpoints and Predictors
As with every statistical modeling approach, including 
URP-CTREE, the choice of the clinical endpoint is central 
because it directly influences (a) which predictors are sig-
nificantly associated with it (step 1 of URP-CTREE), (b) 
where the dichotomous splits are set (step 2 of URP-
CTREE), and (c) how resulting subgroups (nodes) are 
defined. In short, choose your clinical endpoint to assure it 
is appropriate to the “target” of your therapeutic interven-
tion. The same cannot be said for early predictors; any num-
ber of reasonable data traits can be entered into URP-CTREE 
with the only consequence of making the correction for 
multiple testing (eg, Bonferroni) more stringent, but 
Table 3. Summary of key differences between unbiased recursive partitioning (URP-CTREE) and multivariate linear/logistic 
regression models.
Linear/Logistic regression Unbiased Recursive Partitioning
Clinical endpoint (outcome) Choice of investigator Choice of investigator
Early predictors (eg, neurological or functional) Choice of investigator Choice of investigator
Linear effects Assumed Not assumed
Interactions among predictors Usually not considered Considered
Missing values in predictors Not allowed Allowed
Scaling of predictors Difficult to interpret Accounted for
Endpoint considerations Average (mean) only Full distribution
Homogeneous cohort (inclusion/exclusion criteria) Not directly Directly
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URP-CTREE will still only identify those predictors that 
significantly associate with the chosen clinical endpoint. 
URP-CTREE can handle all types of predictors and several 
types of clinical endpoints.10
Limitations
Linear and logistic regression models are most useful when 
the relationship between early predictors and the clinical 
endpoint under investigation is truly linear, but this has not 
been demonstrated for SCI1 or any other central nervous 
system disorder. In settings where this assumption holds, 
established regression methods are likely to outperform 
URP-CTREE in terms of prediction accuracy.
The present study was designed to introduce URP-
CTREE and assess its value for predicting future clinical 
endpoints and stratifying heterogeneous populations. While 
the resampling technique confirms the validity of our con-
clusions, generalizability of URP-CTREE trees shown here 
should be evaluated in independent samples of subjects.
Many clinical assessments like UEMS are analyzed as 
sum scores of different items and often treated as continu-
ous variables for further analysis, even though they are 
ordinal scales. We acknowledge that this could provide mis-
leading results if sum scores do not represent a consistent 
scoring metric. Rasch analysis could provide insight into 
the measurement properties of commonly used clinical 
assessments26 and produce a measurement scale that can be 
more confidently analyzed, but this is beyond the scope of 
the present study.
Conclusion
The results of our analysis show that URP-CTREE provides 
advantages over established multivariate linear and logistic 
regression techniques without compromising prediction 
accuracy. Above all, conditional inference trees are specifi-
cally designed to identify more homogeneous subgroups 
within an initial heterogeneous patient population. Data-
driven, objective decision rules for more homogeneous sub-
group identification can be created and easily implemented 
in clinical studies. URP-CTREE can be applied to all kind 
of regression problems, and could therefore be applied to a 
wide range of neurological disorders where the identifica-
tion of more homogeneous subgroups is desired.
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Introduction
In the field of spinal cord injury (SCI) research, many dis-
coveries from basic research and clinical investigation are 
worthy of consideration as potential SCI therapeutics and 
have entered the translational process (for an overview of 
SCI clinical trials, see www.scope-sci.org). As SCI has a 
relatively low incidence,1 there is a limited number of poten-
tially appropriate acute and subacute trial participants. With 
the increasing number of new interventions, the recruitment 
of participants to acute and subacute SCI trials needs to be 
developed in a more inclusive and effective manner.
If SCI trials only proceed by sequentially enrolling par-
ticipants with very narrow inclusion criteria,2 so as to ensure 
subject homogeneity, enrollment progress will remain slow, 
affecting negatively the timely and financially sustainable 
accomplishment of the planned goals. In addition, with a 
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Abstract
Background. Several novel drug- and cell-based potential therapies for spinal cord injury (SCI) have either been applied or 
will be considered for future clinical trials. Limitations on the number of eligible patients require trials be undertaken in 
a highly efficient and effective manner. However, this is particularly challenging when people living with incomplete SCI 
(iSCI) represent a very heterogeneous population in terms of recovery patterns and can improve spontaneously over the 
first year after injury. Objective. The current study addresses 2 requirements for designing SCI trials: first, enrollment of 
as many eligible participants as possible; second, refined stratification of participants into homogeneous cohorts from a 
heterogeneous iSCI population. Methods. This is a retrospective, longitudinal analysis of prospectively collected SCI data 
from the European Multicenter study about Spinal Cord Injury (EMSCI). We applied conditional inference trees to provide 
a prediction-based stratification algorithm that could be used to generate decision rules for the appropriate inclusion 
of iSCI participants to a trial. Results. Based on baseline clinical assessments and a defined subsequent clinical endpoint, 
conditional inference trees partitioned iSCI participants into more homogeneous groups with regard to the illustrative 
endpoint, upper extremity motor score. Assuming a continuous endpoint, the conditional inference tree was validated 
both internally as well as externally, providing stable and generalizable results. Conclusion. The application of conditional 
inference trees is feasible for iSCI participants and provides easily implementable, prediction-based decision rules for 
inclusion and stratification. This algorithm could be utilized to model various trial endpoints and outcome thresholds.
Keywords
unbiased recursive partitioning, inclusion exclusion criteria, upper extremity motor score, clinical trial design
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narrow recruitment strategy, the scientific gain of knowl-
edge brought about by the completion of a trial will be 
restricted to this narrow SCI subpopulation, requiring addi-
tional studies for SCI subjects with other characteristics and 
being therefore inefficient. Alternatively, once safety has 
been established, a more inclusive strategy would enroll 
participants with varying degrees of sensorimotor complete 
and incomplete SCI (iSCI). However, this can only be sen-
sibly implemented with stratification algorithms to limit 
subject heterogeneity within a study cohort.3,4
Including iSCI participants is justified and required since 
many of the experimental treatments being translated for 
human SCI were developed using animal models with 
incomplete lesions. It is also expected that iSCI trial partici-
pants are more likely to benefit from interventions that tar-
get the spared sensorimotor function. An inclusive 
enrollment strategy will more efficiently utilize potential 
trial participants, as well as decrease the time and therefore 
the costs for completing a SCI trial program.
However, inclusive recruitment and enrollment strate-
gies of iSCI participants poses specific challenges. 
Incomplete SCI comprises a highly heterogeneous popula-
tion in terms of level and severity of injury, as well as the 
diversity of recovery patterns.4 Since iSCI participants have 
some preserved sensory and/or motor function, any adverse 
events could also compromise spontaneous recovery.
Predictive algorithms are required that will quickly and 
accurately exclude those patients whose spontaneous recov-
ery would be so extensive it would obscure any therapeutic 
benefit. In an acute study, the algorithm would have to 
accurately stratify participants on the basis of early clinical 
characteristics. Thus, the selection of sensitive and reliable 
endpoints is critical and such endpoints may be specific to a 
subset of stratified cohorts.
To capitalize on an inclusive recruitment approach, 
while carefully monitoring its limitations, requires the abil-
ity to recognize early clinically relevant subgroups of 
patients. The idea of identifying and stratifying similar 
study participants is demanding, but not new.5 In this study, 
we propose an advanced prediction-based stratification 
approach based on a recently developed Unbiased Recursive 
Partitioning technique called Conditional inference TREEs6 
(URP-CTREE). Our aim is to assess the potential of URP-
CTREE in defining a priori stratifications in a heteroge-
neous neurological disorder as represented by iSCI 
participants.
Methods
Data Source
The data utilized in this study was extracted from the 
European Multicenter study about Spinal Cord Injury 
(EMSCI, www.emsci.org, ClinicalTrials.gov Identifier: 
NCT01571531) according to the inclusion criteria reported 
below. EMSCI encompasses 21 centers from 7 European 
countries that have been tracking the functional and neuro-
logical status of patients during the first year of recovery 
from SCI in a rigorously standardized way since 2001.
Inclusion Criteria
From the 2597 patients present in the EMSCI database, we 
extracted all those de-identified individuals with an initial 
baseline assessment (<2 weeks) having the most caudal spi-
nal segment with intact sensorimotor function (ie, neuro-
logical level of injury [NLI]) between C4 and C7 as defined 
by the International Standards for Neurological 
Classification of Spinal Cord Injury (ISNCSCI)7 and 
described by the American Spinal Injury Association 
Impairment Scale (AIS). SCI participants have typically 
been classified using the 5 grades (A-E) of the AIS. These 
SCI severity categories are broad and have limited value for 
research studies. Nevertheless, it is a commonly used clas-
sification system and a reasonable reference point for 
describing the participants in this study. We included AIS-B 
iSCI participants with sensory perception to S4 to S5, but 
no motor function preserved more than 3 segments below 
the cervical NLI (sensory incomplete SCI), as well as AIS-C 
participants (nonfunctional motor incomplete), where sen-
sory and motor function are partially preserved below the 
NLI, but more than half the key muscles, below the NLI, 
have a muscle grade strength of <3/5. An additional mini-
mum criterion was a neurological assessment at 6 months 
with entry of an upper extremity motor score (UEMS), 
since this was the primary endpoint of this illustrative anal-
ysis. Patients with suspected central cord syndrome8 were 
excluded (n = 5), as routinely done in many clinical trials.
We also excluded from this analysis tetraplegic senso-
rimotor complete (AIS-A) patients, as they have been previ-
ously examined and reported.9 Finally, we excluded cervical 
AIS-D participants. Spontaneous motor recovery after a 
cervical AIS-D injury is substantial with little room on the 
UEMS scale to measure a therapeutic benefit (ie, ceiling 
effect).
Predictors and Clinical Endpoint
Clinical neurological predictors included in this analysis, as 
well as the illustrative clinical endpoint, were selected 
based on the published literature10,11 and clinical experience 
of the authors. The set of clinical characteristics (predictors) 
characterizing the neurological status of patients at baseline 
(assessed <2 weeks after iSCI) included the following: the 
NLI, the right and left motor levels, the right and left sen-
sory levels, the bilateral sensory scores (light touch, pin 
prick), and motor scores (upper and lower extremity motor 
score), as well as epidemiological information, such as age 
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at injury and cause of injury. The set of predictors character-
ize the neurological status of the subjects according to the 
criteria of the ISNCSCI examination.7
The illustrative clinical endpoint chosen for this study 
was the bilateral UEMS at 6 months after injury, which con-
sists of the sum of the manual muscle tested (MMT) strength 
for each of the 10 key muscles of the upper extremity (5 on 
each side of the body) and ranges between 0 and 50. This 
endpoint has been previously related to changes in upper 
extremity function,12 as well as suggested13 as potential 
endpoint in clinical trials. A number of trials also consid-
ered the change in UEMS as primary endpoint.3,14 In this 
regard, we note that the stratification based on our illustra-
tive endpoint does not preclude the use of change in motor 
score as trial endpoint. In fact, the 2 endpoints are strongly 
interconnected and their simultaneous considerations seems 
sensible. First, the direct application of URP-CTREE on the 
change in UEMS creates a situation for which both partici-
pants with severe lesions and those with high initial UEMS 
achieve similar, small change in UEMS (the first due to the 
severity of their lesion, the latter solely due to the ceiling 
effect on the scale used to measure motor function), making 
stratification for trials questionable. In addition, one has to 
consider UEMS so as to know whether the postulated treat-
ment effect (especially if defined on the change in UEMS) 
can actually be measured on the UEMS scale. It should be 
also noted that, since the identification of more homoge-
neous groups with regard to UEMS at 6 months after injury 
is based on baseline UEMS (among others), information on 
changes in UEMS is actually contained in our conditional 
tree (see Figure 1). More generally, UEMS is an impair-
ment-based clinical endpoint and may or may not be the 
most appropriate primary endpoint for a future trial. Phase 
III pivotal trials will likely require a function-based end-
point. Functional (activity-based) endpoints can be ana-
lyzed using the methods described here, but this is beyond 
the scope of this article.
Conditional Inference Trees
In our analysis, we adopted the approach of recursive par-
titioning by conditional inference6 (URP-CTREE). Tree-
based regression models of this type are particularly useful 
for screening heterogeneous patient populations to iden-
tify more homogeneous patient subgroups. In fact, this 
type of approach has been successfully applied in dispa-
rate clinical fields, including cardiovascular disease,15 
genetic marker–tumor association studies,16,17 and trau-
matic brain injury.18
The URP-CTREE algorithm is based on the iterative 
application of a variable selection and a population split-
ting procedure. In the first step, the algorithm assesses 
whether any early clinical predictor (baseline variable) is 
associated with the selected clinical endpoint. To each 
association, a multiple testing-corrected P value based on 
permutation tests is assigned. When no early clinical pre-
dictor conveys any information about the clinical endpoint 
(response variable), and therefore no association is statis-
tically significant (P ≥ .05), the algorithm stops. In con-
trast, when at least one early predictor is significantly 
associated with the selected clinical endpoint, a split in the 
patient population is performed, based on the predictor 
that showed the most significant association with the end-
point. The split is established in a way that maximizes the 
difference between the 2 newly formed subgroups with 
regard to the endpoint. Subgroups that will be further split 
in successive iterations are referred to as inner nodes and 
shown graphically as circles indicating the predictor on 
which a further split is performed (as well as the multiple-
testing corrected P value for the predictor-endpoint asso-
ciation; see upper part of Figure 1). In that sense, inner 
nodes are just graphical placeholders for subgroups that 
Figure 1. Conditional inference tree for the endpoint Upper 
Extremity Motor Score (UEMS) at 6 months after cervical 
motor-incomplete (American Spinal Injury Association 
Impairment Scale B and C) spinal cord injury (N = 122), using a 
broad set of neurological predictors assessed within the first 2 
weeks after injury.
The algorithm led to a partition of the initial patient population into 4 
terminal nodes. Each inner node (nodes 1, 2, 5) presents a cut-point into 
the initial, heterogeneous population and reports the variable selected 
with multiple testing-corrected P value (significance level is P = .05) and 
the split points on the “branches.” The first split separates patients with 
an initial UEMS ≤13 or >13. Further partitioning is based on Light Touch 
(≤54 or >54) and UEMS (≤28 or >28). Terminal nodes (nodes 3, 4, 6, 7) 
display the identified subgroups. Boxplots at the bottom show sample 
size and distribution of the illustrative endpoint UEMS at 6 months after 
injury, defined as the sum of the manual muscle tested (MMT) strength 
for each of the 10 key muscles of the upper extremity (5 on each side of 
the body), and ranging 0 to 50. For more details on the interpretation of 
the conditional inference tree, please refer to the Methods section.
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will be further split by the algorithm. The steps outlined 
above are reiterated until there are no statistically signifi-
cant associations left between early clinical predictors and 
the selected clinical endpoint. When this is the case, the 
algorithm stops and returns a structure resembling an 
upside-down tree that divides an initially heterogeneous 
study population into more homogeneous subgroups with 
respect to the endpoint specified. Figure 1 shows an exam-
ple where the initial, heterogeneous iSCI population 
“enters” the tree on the top inner node and is subsequently 
subdivided by the internal rules of the algorithm till no 
further partitioning is possible. At this stage, the endpoint 
distribution within each subgroup is displayed in the URP-
CTREE’s terminal nodes (see boxplots in Figure 1).
A detailed technical description with several applica-
tions of the statistical model is reported in Hothorn et al,6 
and a more pertinent SCI explanation, using cervical AIS-A 
SCI, has been recently completed.19 In this previous study,19 
we investigated the value of URP-CTREE in comparison to 
established multivariate statistical approaches (eg, linear 
and logistic regression) for predicting clinical endpoints 
and for prospective stratification of sensorimotor-complete 
(AIS-A) SCI participants. Our analyses concluded that, 
while all methods employed had similar prediction accu-
racy, URP-CTREE provided additional advantages by 
directly identifying more homogeneous subgroups of 
patients, and describing the full endpoint distribution within 
each subgroup.
Fitting and Validation
Following model fitting (see Figure 1) with the EMSCI 
data, we inspected the resulting conditional inference tree 
with regard to variable selection and split point estimation. 
Internal validation of the EMSCI-based URP-CTREE was 
investigated by means of a resampling technique. From the 
original EMSCI sample, we drew 1000 random samples 
with replacement. For each random sample (of sample size 
n = 122), we fitted a new conditional inference tree allow-
ing the same predictors. We then investigated the frequency 
of predictor selection and the distribution of split points.
External validity was assessed using a similar but inde-
pendent sample of patient data from the Sygen20 trial. We 
applied the decision rules provided by the inner nodes of the 
EMSCI-based tree (Figure 1) to Sygen participants with ini-
tial characteristics complying with the inclusion criteria 
outlined above. We then compared EMSCI-based terminal 
nodes to the results obtained for Sygen participants. Ninety-
five percent confidence intervals for the median difference 
in all 4 pairs of terminal nodes were computed. All analysis 
were performed in the computing environment R, version 
3.0.1,21 and based on the statistical packages “party: A labo-
ratory for Recursive Partitioning (Version 1.0-13)”22 for 
conditional inference trees, and “coin: Conditional Inference 
Procedures in a Permutation Test Framework (Version 1.0-
23)”23 for confidence interval computation.
Results
Fitting the Conditional Inference Tree
URP-CTREE for UEMS at 6 months based on a sample of 
122 tetraplegic (ie, cervical) AIS-B (n = 53) and AIS-C (n = 
69) participants extracted from EMSCI is shown in Figure 
1. The iterative identification of more homogeneous sub-
groups is based on 2 baseline neurological assessments, 
namely, UEMS and light touch sensory perception. Splits 
are indicated at the inner nodes 1, 2, 5. URP-CTREE pro-
duced 4 terminal nodes (3, 4, 6, 7), for which the endpoint 
distribution is shown in the boxplots at the bottom. Table 1 
reports a numeric summary of outcome distribution as well 
as the initial baseline AIS distribution for each terminal 
node (Figure 1).
Variable Selection
Variable selection is the fundamental step of URP-CTREE 
and relies on the computation of permutation tests between 
predictors and endpoint as well as the identification of the 
most significant associations. The P-value-based ranking of 
the best 4 predictors for each inner node is reported in Table 2. 
Baseline UEMS is the variable selected in inner node 1 (P 
value < .001) and inner node 5 (P value = .001), and base-
line light touch sensation is selected in inner node 2 (P 
value = .024). The EMSCI-based conditional inference tree 
shows a stable variable selection, for which the selected 
variable is clearly the most significant from within all pre-
dictors included in the analysis. The conditional inference 
tree stopped growing (no further split was implemented), as 
no further predictor–endpoint association was significant at 
the P value = .05 level.
Table 1. Distribution of the Illustrative Endpoint UEMS at 6 
Months After Injury for Each Terminal Node in the Conditional 
Inference Tree Based on EMSCI Participantsa.
UEMS Node 3 Node 4 Node 6 Node 7
Minimum  5  6 18 32
25% Quantile 10 23 31.75 41.75
Median 13 30 37.5 44.5
75% Quantile 20 36 42.25 48
Maximum 43 48 50 50
AIS-B (total 53) 8 (15%) 18 (34%) 15 (28%) 12 (23%)
AIS-C (total 69) 5 (7%) 19 (27%) 33 (48%) 12 (17%)
Abbreviations: UEMS, upper extremity motor score; EMSCI, European 
Multicenter study about Spinal Cord Injury; AIS, American Spinal Injury 
Association Impairment Scale.
aBaseline ASIA Impairment Scale grades distribution are also reported.
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AIS Grades
As can be seen in Table 1, the initial classification of iSCI 
severity as AIS-B or AIS-C has little predictive value for the 
distribution of UEMS scores at 6 months. If it did, then most 
of the AIS-B participants would be stratified to cohort 3 where 
the lowest final UEMS scores were recorded and AIS-C par-
ticipants would be more evident within cohort 7 where the 
highest UEMS scores were observed. Instead, a participant 
initially classified AIS-B was just as likely to show a substan-
tial amount of motor function as an AIS-C participant (termi-
nal node 7 has 12 AIS-B and 12 AIS-C). Thus, UEMS after 6 
months could not be predicted by the initial baseline AIS 
grade. AIS-B and AIS-C participants at 6 months were distrib-
uted across all cohorts, often fairly equally.
Split Points
Following variable selection, a split is set so as to maximize 
discrepancy between the 2 newly formed subgroups. The 
split points estimated in each inner node are shown in 
Figure 2. The plots represent the standardized test statistics6 
for each possible split as a measure of subgroup discrep-
ancy; the vertical dotted line is the split point used in the 
EMSCI-based URP-CTREE. All vertical dotted lines 
aligned with the value that maximizes discrepancy between 
the 2 newly formed subgroups. This substantiated the valid-
ity of all 3 split points for the EMSCI-based conditional 
inference model. Even for inner node 2, whose split statis-
tics seem to have 2 local maxima (2 “bumps”), the split was 
produced at the highest value statistic available and was 
therefore correctly implemented.
Internal Validation
We examined the internal validity of the EMSCI-based tree 
using a standard resampling technique and investigated the 
frequency of predictor selection and the distribution of split 
points. Results of this resampling technique are shown in 
Figure 3. For inner node 1, baseline UEMS was selected in all 
resampling iterations (predictor 8, top panel left, Figure 3), 
and the split points resulted in an almost symmetric distri-
bution around the first split point defining the maximal dis-
crepancy for the 2 subgroups in EMSCI (vertical line, top 
panel right).
For inner node 2, baseline light touch was consistently 
selected, and no pattern of alternative variable selection 
emerged (predictor 6, middle panel left, Figure 3). For all 
iterations where light touch was the variable selected, the 
second split point distribution showed an approximately 
symmetric distribution centered at the split point imple-
mented in the EMSCI-based conditional inference tree (ver-
tical line, middle panel right).
Table 2. Variable Selection for the Inner Nodes of the EMSCI-Based Conditional Inference Treea.
Node 1 Node 2 Node 5
Predictors P Value Predictors P Value Predictors P Value
UEMS 3.1 × 10−11 Light touch .024 UEMS .001
ML (right) .0002 UEMS .437 ML (right) .410
ML (left) .001 ML (right) .542 ML (left) .476
NLI .001 Pin prick .868 Age .724
Other predictors Other predictors Other predictors
Abbreviations: EMSCI, European Multicenter study about Spinal Cord Injury; UEMS, upper extremity motor score; ML, motor level; NLI, neurological 
level of injury.
aThe first 4 predictors are reported by increasing P value (decreasing importance). Nominal significance value is P = .05.
Figure 2. Split point estimation of inner nodes for the 
European Multicenter Study about Spinal Cord Injury-based 
conditional inference tree.
Each dot represents a possible partitioning of the patient population 
based on the most significant predictor (early participant characteristic). 
The split statistic is a measure of discrepancy for the 2 newly formed 
subgroups and is maximized by the algorithm such that the split 
partitions the patient population in subgroups that are as different as 
possible. The vertical dotted line represents the split point implemented. 
For more details on the interpretation of the conditional inference tree, 
please refer to the Methods section.
Abbreviation: UEMS, upper extremity motor score.
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For inner node 5, baseline UEMS was consistently 
selected, and no pattern of alternative variable selection 
emerged (predictor 8, bottom panel left, Figure 3). For all 
iterations where UEMS was the variable selected, the third 
split point distribution showed an almost symmetric distri-
bution around the split point implemented in the EMSCI-
based conditional inference tree (vertical line, bottom panel 
right).
External Validation
True validation of a statistical model can only be obtained 
by assessing its performance on an independent data set. We 
analyzed n = 83 participants from the Sygen20 trial (from 
both control and treatment groups, as no significant differ-
ence was reported for these 2 different cohorts) by applying 
the decision rules provided by the inner nodes of the 
EMSCI-based tree and compared its terminal nodes to the 
results obtained for Sygen participants (Figure 4). Overall, 
we observed similar distributions for UEMS within termi-
nal nodes for EMSCI and Sygen subjects.
Terminal node 6 was very similar for both data sets, 
whereas terminal nodes 3 and 7 showed a nonsignificant 
shift in distribution toward slightly higher UEMS values for 
Sygen participants. Terminal node 4 is similar for both data 
sets, especially in terms of interquartile range, but Sygen 
participants show a nonsignificant shift toward lower UEMS 
values. Terminal nodes 4 and 7 for Sygen as well as terminal 
node 3 for EMSCI represent a relatively small sample size.
Based on an asymptotic Wilcoxon Mann–Whitney rank 
sum test, a 95% confidence interval (CI) for the median dif-
ference (EMSCI − Sygen) was computed for each pair of 
terminal nodes. The sample estimate for difference in medi-
ans (hereafter med.diff) and relative 95% CIs were the fol-
lowing: med.diff (node 3) = −6.0 (CI: −13.0, 2.0); med.diff 
(node 4) = 3.0 (CI: −7.0, 13.0); med.diff (node 6) = 0.0 (CI: 
−4.0, 4.0); med.diff (node 7) = −2.0 (CI: −5.0, 0.0).
Discussion
The intent of this study was to determine whether well-
informed and predictable stratification algorithms can be 
achieved for an acute or subacute SCI clinical trial. Previously, 
this has been difficult because of the highly variable spontane-
ous recovery patterns after iSCI. There is a strong need for a 
clear a priori stratification algorithm and, as seen with the cur-
rent example, URP-CTREE may be useful in this regard. The 
advantage of this tree-based regression model is its ability to 
automatically stratify participants into relatively homoge-
neous subgroups on the basis of early clinical characteristics.
Figure 3. Internal validation of variable selection and split point estimation based on resampling.
For each inner node, predictor (early participant characteristic) selection (left panels) and split point estimation (right panels) are shown. The vertical 
line in the split point distribution represents the split implemented in the EMSCI-based conditional inference tree.
Abbreviations: EMSCI, European Multicenter study about Spinal Cord Injury; UEMS, upper extremity motor score.
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So far, very few studies in SCI have attempted to provide 
models for long-term prediction of neurological endpoints 
that could be used for patient stratification. To our knowledge, 
existing clinical algorithms refer to ambulatory24,25 or func-
tional26 endpoints, which require substantial recovery and are 
therefore likely to depend on either a large treatment effect 
and/or spontaneous recovery. Thus, they are potentially less 
useful for application to an acute SCI clinical trial investigat-
ing a subtle therapeutic effect that would be initially detect-
able by some small neurological change. In addition, those 
functional endpoint studies are based on the statistical tech-
niques of multiple linear and logistic regression. In a recent 
study,19 we reported that those techniques do not provide 
direct rules for identifying more homogeneous cohorts and do 
not consider the full endpoint distribution. Here, we demon-
strate the value of conditional inference trees6 to provide an 
easily implementable, data-driven stratification rationale for 
the inclusion of iSCI into future SCI trial programs.
Conditional Inference Tree for EMSCI Data
The conditional inference tree for tetraplegic AIS-B and 
AIS-C based on EMSCI data produces 3 split points based 
on baseline UEMS and baseline light touch sensation 
(Figure 1). All 3 split points (inner nodes 1, 2, 5; Figure 1) 
are based on the most significant predictor (early partici-
pant characteristic) at that inner node.
As expected, baseline UEMS after iSCI plays an impor-
tant role in predicting UEMS values 6 months later. A non-
linear relationship between baseline UEMS and the 
6-month value is clearly shown by the 2 subsequent splits 
of baseline UEMS, as has been shown for general motor 
recovery in previous studies.4,20 The lower range of UEMS 
is further divided depending on the perception of light 
touch. In our analysis, light touch was clearly more predic-
tive for future UEMS than pin prick sensation (see Table 
2). This seems to be in contrast with previous findings.4,27 
Those findings predicted ambulation for motor complete, 
sensory incomplete (AIS-B) participants based on their 
lower extremity and sacral pinprick score. Our results are 
therefore complementary rather than contrasting.
Although not always statistically significant, Table 2 
also shows that the baseline motor level is consistently 
ranked within the first 3 most important predictors for each 
node. The relevance of the motor level for spontaneous 
motor recovery is dependent on the nature of SCI and has 
been reported before.28 Its explicit incorporation in future 
analysis of motor endpoints is warranted.
AIS Grades for SCI Patient Stratification
Over the past few decades, stratification procedures for SCI 
trials were narrow,2 broad,3 or omitted.14 Clinicians have 
been classifying SCI in wide-ranging categories, the most 
Figure 4. External validation of EMSCI-trained conditional inference tree based on Sygen participants with corresponding baseline 
characteristics.
EMSCI-derived terminal nodes (light gray) were compared to Sygen-derived terminal nodes (dark gray) provided by applying the splits provided by the 
EMSCI-based conditional inference tree. Boxplot width is proportional to available sample size, which is reported at the bottom.
Abbreviations: EMSCI, European Multicenter study about Spinal Cord Injury; UEMS, upper extremity motor score.
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common of which is the AIS classification. As can be seen 
in Table 1, the initial classification of iSCI severity as AIS-B 
or AIS-C had little predictive value for the distribution of 
participants with regard to their scores at 6 months. AIS-B 
and AIS-C participants were distributed across all cohorts, 
often fairly equally (Figure 1, nodes 3, 4, 6, 7). AIS grades 
have been repeatedly proven not to be a valuable measure 
for endpoint definition,2,13,20 especially so in the context of 
SCI clinical trials with expected small treatment effects. 
Our analysis, even though based on AIS-B and AIS-C par-
ticipants only, and other studies29 show that AIS grades 
might not be appropriate for a fine-grained stratification as 
required by clinical trial either.
Validation
The main goal of any clinical predictive model is to provide 
valid endpoint predictions for future participants.30 With the 
goal to investigate the stability and generalizability of con-
ditional inference tree, we undertook internal and external 
validation of our results.
Internal validation was based on resampling and showed 
that predictor selection was consistent for all inner nodes, 
where the predictors selected in the EMSCI-based URP-
CTREE were reliably selected (Figure 3, left panels) across 
resampling iterations. In addition, no pattern of selection 
for other predictors emerged from the resampling tech-
nique. The split point distribution for the predictors showed 
an approximately symmetric distribution around the origi-
nal split (vertical line in right panels, Figure 3). Both pre-
dictor selection and split point distribution provide strong 
evidence for the stability of the EMSCI-based conditional 
inference tree.
To externally validate and support the general applicabil-
ity of our conditional inference tree for UEMS, we applied 
the decision rules provided by the inner nodes of the 
EMSCI-based tree to an independent sample of Sygen par-
ticipants (n = 83; from both control and treatment groups, as 
no significant difference was reported). Overall, we 
observed similar terminal nodes (final subgroups, Figure 4) 
for EMSCI and Sygen subjects, which provides evidence 
for the external validity of the EMSCI conditional inference 
tree. Similarities between European and North American 
spontaneous recovery profiles have already been reported 
for motor recovery after sensorimotor complete cervical 
(AIS-A) SCI.31 Our analyses suggest that parallels extend to 
the iSCI population.
Specifically, nodes 3 and 4 (Figure 4) for Sygen patients 
provided a less sharp distinction between low (EMSCI box-
plot node 3, Figure 4) and intermediate (EMSCI boxplot 
node 4, Figure 4) UEMS status at 6 months after injury. 
Terminal node 3 in Sygen showed higher UEMS scores 
than the corresponding EMSCI terminal node, while termi-
nal node 4 presents the opposite behavior.
The different enrollment time frames of Sygen (first 
assessment within 3 days of SCI) compared to EMSCI (first 
assessment within 2 weeks, in average 8 days after injury) 
may contribute to any observed differences in terminal 
nodes. To support our hypothesis, we selected those EMSCI 
participants (n = 25) having an initial baseline assessment 
within 3 days of injury (ie, same time window as for Sygen), 
and we noted a median UEMS of 38 at 6 months. For those 
EMSCI participants that had an initial assessment >3 days 
after injury (n = 97), the median UEMS was 34 at 6 months. 
This analysis performed on the EMSCI data support our 
interpretation that enrollment time frame can influence 
UEMS outcomes.
Despite the observed differences (Figure 4), all 95% 
confidence intervals for the median difference of each ter-
minal node pair included the value of zero, providing no 
evidence for a statistically significant shift in distribution in 
our data. Nonetheless, absence of evidence cannot be inter-
preted as evidence of absence, especially because of the 
small sample sizes.
While assessing external validity, we explicitly did not 
fit a new URP-CTREE to the Sygen data set as the goal of 
external validation is to see whether a fitted model provides 
valid prediction of an endpoint for an independent data set, 
and not whether the same model results from the 2 different 
datasets.
Applications to Clinical Trial Design
Our analysis was intended to provide an illustrative exam-
ple of how URP-CTREE may be employed in the planning 
and designing of future clinical trials. Of the 4 nodes (3, 4, 
6, 7) in Figure 1 and Table 1, a conservative enrollment 
strategy of iSCI participants in a phase II SCI clinical trial 
would only include participants within nodes 4 and 6. In 
this way, enrollment is restricted to iSCI participants that 
are likely to respond to a treatment, and participants where 
any treatment effect can be readily detected. In short, the 
assessment of a treatment effect is not hampered by floor or 
ceiling effects for the endpoint measurement. Participants 
in node 7 would likely be excluded because they will be 
constrained by a ceiling effect for the UEMS scale. For 
node 7, the median UEMS at 6 months is 44.5/50. Thus, 
only 5.5 motor points are available to detect a therapeutic 
effect in comparison to controls.
Participants in terminal node 3 could be excluded as 
well, because they show limited final upper extremity 
scores and any treatment targeting the enhancement of their 
spared sensorimotor function might only have a small 
effect. In addition, those participants are distinctly different 
from the other iSCI nodes in terms of final UEMS. In terms 
of UEMS and improvement in motor levels, the patterns for 
node 3 participants were very similar to those of cervical 
sensorimotor complete (AIS-A) participants and a similar 
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clinical endpoint (2 motor level improvement) might be jus-
tified.9,32 Therefore, iSCI participants like those in terminal 
node 3 could be stratified with cervical AIS-A participants 
in a clinical trial with an appropriate endpoint.
The potential number of eligible iSCI participants that 
may be recruited to any clinical study is an important con-
sideration. Even if we applied the more restrictive criteria 
and suggested only recruiting participants within nodes 4 
and 6 (Figure 1), a hypothetical trial could potentially still 
recruit 70% of eligible iSCI subjects (EMSCI sample = 37 
+ 48/122 = 70%). Undoubtedly, a number of other inclusion 
and exclusion criteria will influence the final number of 
participants enrolled (the “funnel effect”33) but the potential 
inclusion of such a large percentage of iSCI combined with 
the a priori identification of more homogeneous subgroups 
represents a clear improvement in trial design.
Modeling Specific Endpoints
Independent from its use in clinical trials, one of the key 
advantages of URP-CTREE with respect to established sta-
tistical approaches24-26 is that it presents a complete end-
point distribution within the terminal nodes.19 This allows 
the exploration of different neurological or functional end-
points and their appropriateness for distinct iSCI subgroups 
(terminal nodes).
Clearly, the use of URP-CTREE does not guarantee par-
titioning of a heterogeneous population in the same way as 
presented here. URP-CTREE is specific for a given patient 
population, clinical endpoint, and early clinical predictors 
(baseline variables). Changes in any of these components 
may influence the resulting partitioning by generating dif-
ferent splits, a different number of terminal nodes (sub-
groups), or a different endpoint distribution within each 
node.
With any comprehensive historical database, URP-
CTREE can be employed to accomplish all the necessary 
modeling variations and gather insight into the expected 
behavior of the control group for any chosen endpoint. This 
is a major improvement and should provide additional con-
fidence for the final trial protocol submission. In the study 
reported here, we have deliberately not chosen a threshold 
value for UEMS at 6 months after iSCI. A threshold for a 
binary endpoint could be explored using URP-CTREE, but 
selection of any endpoint threshold requires consideration 
of what is reasonable and/or meaningful.
Limitations
URP-CTREE is applicable to several types of regression 
problems, including nominal, ordinal, numeric, and cen-
sored endpoints.6 It remains to be demonstrated whether 
neurological scores like UEMS can actually be analyzed as 
a continuous endpoint, such as time or distance. Despite 
being the current default approach in SCI, total UEMS is in 
fact a sum of several ordinal variables (each manual muscle 
score, from a key muscle, is an ordinal scale in its own 
right). In other fields, it has been shown that the analysis of 
an ordinal scale with methods designed for the analysis of 
continuous endpoints led to errors in inference.34-36 We are 
analyzing methods for correcting this limitation.
Conclusion
Our analyses provide an example for the employment of 
URP-CTREE to facilitate the design of more inclusive 
clinical trials. We utilized a conditional inference tree to 
provide an early prediction-based stratification of cervical 
iSCI patients as anchored by UEMS at 6 months after 
injury (inclusion/exclusion criteria). Internal validation of 
the EMSCI determined URP-CTREE proved it to be very 
stable. External validation based on comparable incom-
plete SCI participants from the independent Sygen study 
supports its generalizability. Our analysis supports the use 
of URP-CTREE as a statistical tool for modeling various 
other clinical endpoints and different patient populations. 
Further investigations on the external validity and the 
analysis of ordinal variables with techniques designed for 
continuous endpoint should be the object of refined 
analysis.
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Abstract
Background: A number of potential therapeutic approaches for neurological disorders have failed to provide
convincing evidence of efficacy, prompting pharmaceutical and health companies to discontinue their involvement
in drug development. Limitations in the statistical analysis of complex endpoints have very likely had a negative
impact on the translational process.
Methods: We propose a transitional ordinal model with an autoregressive component to overcome previous
limitations in the analysis of Upper Extremity Motor Scores, a relevant endpoint in the field of Spinal Cord Injury.
Statistical power and clinical interpretation of estimated treatment effects of the proposed model were compared to
routinely employed approaches in a large simulation study of two-arm randomized clinical trials. A revisitation of a key
historical trial provides further comparison between the different analysis approaches.
Results: The proposed model outperformed all other approaches in virtually all simulation settings, achieving on
average 14 % higher statistical power than the respective second-best performing approach (range: -1 %, +34 %).
Only the transitional model allows treatment effect estimates to be interpreted as conditional odds ratios, providing
clear interpretation and visualization.
Conclusion: The proposed model takes into account the complex ordinal nature of the endpoint under
investigation and explicitly accounts for relevant prognostic factors such as lesion level and baseline information.
Superior statistical power, combined with clear clinical interpretation of estimated treatment effects and widespread
availability in commercial software, are strong arguments for clinicians and trial scientists to adopt, and further extend,
the proposed approach.
Keywords: Upper extremity motor scores, Summed overall score, Multivariate ordinal endpoints, Proportional odds
model, Statistical power, Spinal cord injury, Sygen®trial, Rasch models, Latent variable models
Background
Neurological research is responsible for the investigation
of many devastating disorders such as stroke, Alzheimer’s
and Parkinson’s diseases. In terms of health costs, brain-
related disorders are a greater socio-economic burden
than cancer, cardiovascular diseases and diabetes com-
bined [1], with yearly costs for the European society
estimated at almost 400 billion e [2].
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Despite several therapeutic approaches [3–6] based on
recent discoveries of cellular and molecular processes of
degeneration, but also spontaneous regeneration follow-
ing injury, pharmaceutical and health companies have
been withdrawing from neuroscience, as a number of
trials intended to show efficacy of treatments for neu-
rological disorders failed [7]. In the field of Spinal Cord
Injury (SCI), four decades after the first pharmacological
treatment of acute injuries [8], the promises of preclini-
cal discoveries have yet to be translated into a standard
treatment [9].
To streamline the translational process, the Interna-
tional Campaign for Cures of Spinal Cord Injury Paralysis
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
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(ICCP) appointed in 2007 an international panel with the
task to reviewing strengths and weaknesses of clinical
trials in spinal cord injury. Their recommendations for
the planning and conduction of future trials were con-
densed in a series of publications [10–13], which strongly
influenced the conception of clinical trials thereafter [14].
Nonetheless, the ICCP reviews [10–13] did not solicit
the application of the most appropriate and recent statis-
tical techniques available for the analysis of complex SCI
trial endpoints, and many clinical trials failed to do so
too [15–19].
In fact, virtually all routinely performed clinical assess-
ments in spinal cord injury are measured on ordinal
scales, which are characterized by an arbitrary numer-
ical score establishing a ranking of observations. The
difference between two following ranks is by no means
bound to be equivalent across the range of the scale,
preventing standard operations such as addition, and
making the use of statistical methods developed for
continuous endpoints inappropriate. Despite this, clini-
cal trials designed and powered for a primary ordinal
endpoint often resorted to adding several ordinal end-
points to form a single overall summed score, which is in
some cases subsequently collapsed to a binary outcome
[15–19]. These approaches have been shown to be inap-
propriate in a number of aspects [20], and practical con-
sequences such as biased parameter estimates, misleading
associations and loss of power are some of the known
consequences of assuming metric properties for ordinal
endpoints [21–23].
In this study, we propose for the first time in SCI a
transitional ordinal model with an autoregressive com-
ponent for testing for treatment effect on a multivariate
ordinal endpoint such as the Upper Extremity Motor
Scores (UEMS), while comparing it to current analy-
sis approaches in terms of statistical power and clinical
interpretation of treatment effect estimates.
Methods
The objective was to propose a new approach to the
analysis of complex ordinal endpoints in neurological
clinical trials, and provide statistical power comparisons
of procedures for treatment effect testing. Two-armed
Randomized Clinical Trials (RCT) with specific levels
of experimental conditions were generated and analysed.
Current approaches to the analysis of multivariate ordi-
nal endpoints such as the Upper Extremity Motor Scores
(UEMS) were compared to the proposed autoregressive
transitional ordinal model. The proposed approach mod-
els the transition, e.g. the change in UEMS distribution,
from trial baseline to trial end. The autoregressive term
of the model describes the anatomical structure of the
spinal cord by postulating a direct dependency between
contiguous segments.
Data source and trial endpoint
The data utilized in this study was extracted from the
European Multicenter Study about Spinal Cord Injury
(EMSCI, ClinicalTrials.gov Identifier: NCT01571531,
www.emsci.org). EMSCI tracks the functional and neu-
rological recovery of patients during the first year after
spinal cord injury in a highly standardized manner. All
patients gave written informed consent. The ethical com-
mittee of the Canton of Zurich, Switzerland, has pre-
viously approved the EMSCI project, upon which this
project is based, and the approval is also valid for any
statistical analysis/re-analysis.
To reflect the time frame of a possible future clinical
trial, we considered baseline (within 2 weeks after injury,
t = 1) and one follow-up (6 months after injury, t =
2) examination. For this simulation study, we extracted
and utilized records of N=405 patients with a Motor
Level (ML) defined between spinal segments C5-T1 (see
Additional file 1 for details) and with available baseline
information.
The trial endpoint considered is the Upper Extremity
Motor Scores. UEMS represents a subset of the Interna-
tional Standards for Neurological Classification of Spinal
Cord Injury (ISNCSCI) [24] and describes themuscle con-
traction force for 10 key muscles on the arms and hands (5
on each body side), each one being rated on a 6-point ordi-
nal scale (0: total paralysis, through 5: active movement
against full resistance, see Additional file 1 for details).
Accordingly, Yi,m,t is the muscle contraction score for
patient i (i = 1, . . . , n) and key muscle m (m = 1, . . . , 10)
measured at time point t (t = 1, 2). Each key muscle
Yi,m,t is therefore an ordinal variable with k = 6 levels
0 < 1 < . . . < 5, and UEMS is a multivariate ordi-
nal endpoint. The chosen endpoint is particularly relevant
in SCI. A change in total UEMS over trial period has
been employed repeatedly in clinical trials [15, 19] and
has been suggested to correlate with changes in activities
of daily living that rely on recovery of upper extremity
function [25].
RCT simulation
An autoregressive transitional ordinal model of the form:
logit
[
P(yi,m,2 ≤ k)
] = αj + βlev xlev,i,m,1 + βbase ybase,i,m,1
+ βauto yauto,i,m−1,2
(1)
was fitted on the EMSCI data. αj are the k − 1 = 5 inter-
cept parameters, xlev is a 10-level nominal factor denoting
the combination of Motor Level and the distance from
the Motor Level to the key muscle m being analysed,
expressed as number of key muscles along the spine (ref-
erence: motor level: cervical C5, distance: -1 (first muscle
- 56 - Paper III
Tanadini et al. BMCMedical ResearchMethodology  (2016) 16:149 Page 3 of 13
below the level)), ybase,i,m,1 is the ordered factor for base-
line motor score of key muscle m, and yauto,i,m−1,2 is the
ordered factor for motor score of the key muscle just
above the one being analysed at t = 2. The autoregres-
sive term of the model describes the anatomical structure
of the spinal cord, and postulates that the motor score of
a given key muscle depends on the Motor Score of the key
muscle just rostral to it. As a consequence, the observed
pattern of lower motor scores with increasing distance
from the ML is reproduced. In accordance with the above
description, Eq. 1 simulated and analysed only key mus-
cle score below the Motor Level. Motor scores yi,m,2 for
key muscles at ML were multinomially sampled from cor-
responding observed EMSCI frequencies at Motor Level,
while motor scores yi,m,2 for key muscles above the ML
were given the maximal score.
The parameter estimates recovered from the model
specified in Eq. 1 describe the spontaneous neurological
recovery for patients under standard of care and were sub-
sequently used to simulate participants in the control arm
of the trial. From the EMSCI data we also computed the
observed frequencies of Motor Level combinations for the
left and right body side at baseline. Given that patients
having both left and right ML at the lowest UEMS key
muscles T1 are very rare (3 % in our EMSCI sample) and
do not contribute to the analysis (no key muscles in the
UEMS below the ML), they were not included into the
simulation.
Equation 1 models the spontaneous neurological recov-
ery for patients under standard of care. We introduced
an additional parameter βtrt representing a postulated
treatment effect, leading to an autoregressive transitional
ordinal model of the form:
logit
[
P(yi,m,2 ≤ k)
] = αj + βlev xlev,i,m,1 + βbase ybase,i,m,1
+ βauto yauto,i,m−1,2 + βtrt xtrt,i,1
(2)
As previously defined, αj are the k − 1 = 5 inter-
cept parameters, xlev is a 10-level nominal factor denoting
the combination of Motor Level and the distance from
the Motor Level to the key muscle m being analysed,
expressed as number of key muscles along the spine (ref-
erence: Motor Level: C5, distance: -1), ybase,i,m,1 is the
ordered factor for baseline motor score of key muscle
m, yauto,i,m−1,2 is ordered factor for motor score of the
key muscle just above the one being analysed at t = 2,
and xtrt is an indicator for treatment arm with placebo as
reference.
The autoregressive term of the model describes the
anatomical structure of the spinal cord, and postulates
that the motor score of a given key muscle depends
on the motor score of the key muscle just rostral to it.
As a consequence, the observed pattern of lower motor
scores with increasing distance from the ML is repro-
duced. Besides the postulated treatment effect βtrt, which
is set to different values depending on the simulation set-
tings, all other parameters in Eq. 2 were kept equal to
the estimates recovered by fitting Eq. 1 to the EMSCI
data.
We thus simulated randomized clinical trials with two
treatment arms and specific levels of experimental condi-
tions. To cover possible SCI early phase as well as phase
III settings, we generated total trial sample sizes of 50, 75,
100, 125, 150, 175, 200 participants. To our knowledge,
there is to date no publication on the magnitude of possi-
ble treatment effects for UEMS which could have guided
us in defining more tailored scenarios. We therefore pos-
tulated a rather wide range of six possible treatment
effects (from no treatment effect (βtrt = 0.0 = log(1))
to strong treatment effect (βtrt = 0.4055 = log(1.5))
in 0.1 steps). A total of 42 scenarios resulted from sim-
ulating all possible combinations of the 7 trial sample
sizes and 6 possible treatment effects considered. Being
a proportional odds model, the exponentiated βtrt can be
interpreted as conditional Odds Ratio (OR) between trial
arms, meaning that, conditional on all other prognostic
factors being equal, it specifies the ratio of the odds for a
key muscle to achieve a motor score of less than or equal
to k in the treatment arm divided by the same odds in
the control arm. OR is a statistically sensible and clinical
widely accepted way of quantifying effects of categorical
variables.
The 42 trial scenarios resulting from all combinations of
7 trial sample sizes and 6 possible treatment effects were
simulated in the following way:
1. Right and left Motor Levels for the hypothesized
number of trial participants were drawn from a
multinomial distribution with category probabilities
set to the corresponding observed EMSCI
frequencies.
2. Baseline UEMS for each trial participant were
sampled with replacement from all EMSCI patients
having the same left-right ML constellation.
3. Each simulated participant was randomly allocated
to either the control or the treatment arm with a 1:1
allocation scheme.
4. UEMS at six months for the key muscle at ML were
drawn from a multinomial distribution with category
probabilities set to the corresponding observed
EMSCI frequencies.
5. UEMS at six months below the ML were simulated
using the previously fitted model for spontaneous
recovery (Eq. 1) for participants in the control arm,
and the same model with the addition of a postulated
treatment effect (Eq. 2) for participants in the
treatment arm of the trial.
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6. Each one of the 42 trial scenarios was replicated 1000
times.
7. A battery of 6 different tests for treatment effect (see
below “Endpoint analysis approaches” Section) were
applied to each simulated trial.
8. The statistical power = P(reject H0|H1 is true) was
estimated as the fraction of significant tests for
treatment effect at the nominal level 0.05 among the
1000 replications.
Endpoint analysis approaches
In neurology in general, and SCI in particular, very com-
mon approaches to the analysis of UEMS or similar end-
points are as the total sum of all motor scores Y ∗i,2 =∑10
m=1 Yi,m,2 or as difference between two time points
Y ∗∗i =
∑10
m=1 Yi,m,2 − Yi,m,1. Accordingly, treatment effect
for UEMS was tested with:
t-test: t-test for Y ∗i,2, comparing mean total UEMS in the
two treatment groups.
t-test delta: t-test for Y ∗∗i , comparing the mean differ-
ence in total UEMS from baseline to the end of the
trial between the two treatment groups.
ANCOVA: Analysis of covariance for Y ∗i,2, comparing
mean total UEMS in the two treatment groups with
baseline total UEMS Y ∗i,1 as controlling continuous
variable.
Even though not commonly done in SCI, we considered
necessary that the Motor Level should be incorporated
into the analysis of motor function. In fact, its impor-
tance has been reported before [26, 27]. We therefore
applied a conditional test of independence between out-
come and treatment arm which was stratified according
to the Motor Level of each trial participant. We pre-
dicted that this approach would perform better than the
previous, not stratified ones, and explored the possibil-
ity to utilise them as “ad hoc” approach for the analysis
of UEMS. Accordingly, treatment effect for UEMS was
tested with:
i-test: stratified independence test for Y ∗i,2, comparing
total UEMS in the two treatment groups.
i-test delta: stratified independence test for Y ∗∗i , com-
paring the difference in total UEMS from baseline
to the end of the trial between the two treatment
groups.
Both tests are implemented in the R add-on package coin
[28, 29].
The last approach for the analysis of UEMS in a RCT is
a model that takes into account the ordinal nature of each
key muscle and explicitly incorporates baseline UEMS as
well as ML into the analysis:
transitional: transitional ordinal model for Yi,m,2 of the
form specified in Eq. 2, comparing the shift in motor
score probabilities associated with treatment.
The proposedmodel is a proportional odds model with an
autoregressive component. The latter takes into account
the spatial orientation of the key muscles along the spinal
cord by postulating a direct dependency of adjacent spinal
segments. As a consequence, the observed pattern of
lower Motor Scores with increasing distance from the ML
is reproduced. This model was fitted using function polr
from the R add-on packageMASS [30, 31].
The parameter βtrt, which quantifies the treatment
effect on the link scale, is the focus of the proposed model.
Its significance testing was based on a permutation test
[32, 33], where the distribution of the test statistics under
H0 (no treatment effect) was based on refitting the same
model 1000 times after randomly rearranging the labels
for arm allocation. This type of statistical significance test
does not rely on any distributional assumption. In addi-
tion, by permuting trial arm allocation at participant level,
we accounted for the hierarchical structure of the data
analysed, where multiple key muscles are measured on
the same participant. All computations were performed in
the R system for statistical computing [34], version 3.1.3.
The R code implementing the simulation study is available
online (doi: http://dx.doi.org/10.5281/zenodo.47600).
Revisiting a key SCI trial
As a practical application, we analysed a subset of the
data collected during a past clinical trial. The Sygen
®trial recruited N=760 SCI participants in 28 centres in
North-America in a 5-year period between 1992 and 1997
[17, 35, 36]. Sygen ®is a naturally occurring compound in
cell membranes which has been associated with neuro-
protective and regenerative effects in a number of exper-
imental models and early-phase human trials. The trial is
an example where a promising therapeutic approach was
finally abandoned, as no significant treatment effect could
be assessed on the primary endpoint despite a consid-
erable final sample size (N=760). The primary endpoint
assessed the overall neurological status of a patient and
was defined as a dichotomization derived from an ordinal
scale (see [36] for the exact definition). The primary end-
point was analysed bymeans of logistic regression. Several
ancillary analyses were performed and mostly preferred
the treatment arm, even though the differences were not
always statistically significant. To our knowledge, no anal-
ysis performed at the level of motor scores of the upper
extremity key muscles UEMS as reported here have been
published.
We revisited the trial by testing for treatment effect on
the UEMS with all six approaches outlined before (see
“Endpoint analysis approaches” Section). The proposed
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autoregressive transitional ordinal model (Eq. 2) can be
easily fitted as proportional odds model to the segment-
wise UEMS data in the long format. The autoregressive
component yi,m−1,2 can be incorporated by shifting the
six-month, muscle-wise UEMS entries so as to be aligned
to the key muscle yi,m,2 just caudal to them.
To reflect our simulation study, we selected participants
with a ML between C5 - C8 (T1 were discarded, because
there is no key muscle caudal to the ML on the UEMS),
and considered only patients treated with a low dosage
(the original trial had two treatment doses, the higher of
which was abandoned during the study). After patients
selection, we analysed a finale sample of N=284 par-
ticipants, 127 (45 %) of which in the control arm. This
analysis is intended to give an example of the applica-
tion of the proposed transitional ordinal model, but is not
intended and should not be taken as a definitive conclu-
sion about the value or outcome of the trial. Given the
strongly selected patients sample utilised, the different
endpoint analysed and the different scope of our analysis,
generalizations of this type cannot be drawn.
Results
RCT simulation
For the purpose of this study, we simulated 1000 times
each one of the 42 different combinations of trials size
and postulated treatment effect. Statistical power, which
is defined as the probability of rejecting the H0 of no
treatment when there is in fact a treatment effect, was
estimated as the fraction of this 1000 iterations where
the test for treatment effect resulted significant at the
0.05 level. Table 1 reports the statistical power of all
treatment testing approaches for all simulated settings.
Figure 1 shows the statistical power of all six approaches
for the intermediate treatment effect simulated. Figure 2
displays graphically the statistical power of all treatment
testing approaches for all simulated settings. The nomi-
nal level 0.05 was maintained by all approaches when no
treatment effect was introduced in the simulation, mak-
ing further comparisons between different approaches
straightforward.
For the smallest treatment effect βtrt = 0.0953 =
log(1.1), all six tests for treatment effect showed a
low power, never exceeding P(reject H0|H1 is true)
≤ 0.135. The transitional ordinal model was nonethe-
less superior to all other approaches in virtually every
trial size setting, its power point estimates averaging
2.3 % higher than the respective second best-performing
approach.
Already at the next higher treatment effect simulated
βtrt = 0.1823 = log(1.2), the transitional ordinal model
showed roughly twice as much power as the second-best
performing approach, though it did not exceed P(reject
H0|H1 is true) ≤ 0.36. This held for all simulation settings
except the smallest sample size. Statistical power point
estimates for the transitional ordinal model were on
average 10.3 % higher than the respective second best-
performing approach.
In the settings with median simulated treatment effect
βtrt = 0.2624 = log(1.3) shown in Fig. 1, the transi-
tional ordinal model was superior for all trial sizes. Power
point estimates for the proposed model were on average
19.4 % higher than the respective second best-performing
approach, with this difference in performance increasing
with increasing trial size.
With the simulated treatment effect of βtrt = 0.3365 =
log(1.4), the transitional ordinal model had superior sta-
tistical power of 26.3 % on average, compared to the
respective second best-performing approach, with this
difference increasing with increasing trial size.
For the largest simulated treatment effect of βtrt =
0.4055 = log(1.5), the transitional ordinal model had an
average superior statistical power of 27.9 %, compared to
the respective second best-performing approach. The dif-
ference in performance increased strongly up to trial size
N=100, but then declined with larger sizes.
Overall, despite a comparably poor performance of all
approaches for small simulated treatment effects, a stable
pattern in the ranking of performance emerged: the pro-
posed transitional ordinal approach provided best power
results in virtually all settings. ANCOVA was usually
the second-best approach, closely followed by the inde-
pendence test on the difference of UEMS from baseline
Y ∗∗i , the similarly performing t-test on the difference
of UEMS from baseline Y ∗∗i and the independence test
on the UEMS after six months Y ∗i,2. The t-test on the
UEMS after six months Y ∗i,2 performed worst in almost all
settings.
Revisiting a key SCI trial
We analysed a subset of the data collected during the
Sygen ®trial [17, 35, 36]. To our knowledge, no analysis
on this data has been performed at the level of motor
scores of the upper extremity key muscles UEMS as
reported here. The results of the six analysis approaches
(see Endpoint analysis approaches section) are reported
here:
t-test: No significant difference in the estimated means
μ̂ctrl = 30.370 and μ̂trt = 30.170 of UEMS at 6
months between trial arms: t(275)=0.130, p−value =
0.896.
t-test delta: No significant difference in the estimated
mean change μ̂ctrl = 11.978 and μ̂trt = 10.540 of
UEMS between trial arms: t(259)=1.239, p−value =
0.216.
ANCOVA: No significant difference in the estimated
means of UEMS at 6 months between trial arms,
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Table 1 Statistical power for all simulation settings. Point estimates, as well as Wilson confidence intervals are reported for all analysis approaches
Size Treatment OR T-test CI lower CI upper T-test delta CI lower CI upper I-test CI lower CI upper I-test delta CI lower CI upper ANCOVA CI lower CI upper Transitional CI lower CI upper
50 0.0000 1.0 0.053 0.041 0.069 0.052 0.040 0.068 0.051 0.039 0.066 0.042 0.031 0.056 0.046 0.035 0.061 0.050 0.038 0.065
75 0.0000 1.0 0.048 0.036 0.063 0.050 0.038 0.065 0.052 0.040 0.068 0.051 0.039 0.066 0.053 0.041 0.069 0.052 0.040 0.068
100 0.0000 1.0 0.047 0.036 0.062 0.046 0.035 0.061 0.054 0.042 0.070 0.046 0.035 0.061 0.048 0.036 0.063 0.045 0.034 0.060
125 0.0000 1.0 0.049 0.037 0.064 0.052 0.040 0.068 0.040 0.030 0.054 0.056 0.043 0.072 0.056 0.043 0.072 0.057 0.044 0.073
150 0.0000 1.0 0.056 0.043 0.072 0.044 0.033 0.059 0.041 0.030 0.055 0.040 0.030 0.054 0.050 0.038 0.065 0.040 0.030 0.054
175 0.0000 1.0 0.050 0.038 0.065 0.050 0.038 0.065 0.043 0.032 0.057 0.053 0.041 0.069 0.042 0.031 0.056 0.047 0.036 0.062
200 0.0000 1.0 0.051 0.039 0.066 0.052 0.040 0.068 0.046 0.035 0.061 0.053 0.041 0.069 0.056 0.043 0.072 0.048 0.036 0.063
50 0.0953 1.1 0.057 0.044 0.073 0.060 0.047 0.076 0.063 0.050 0.080 0.052 0.040 0.068 0.062 0.049 0.079 0.049 0.037 0.064
75 0.0953 1.1 0.055 0.042 0.071 0.056 0.043 0.072 0.051 0.039 0.066 0.069 0.055 0.086 0.049 0.037 0.064 0.086 0.070 0.105
100 0.0953 1.1 0.057 0.044 0.073 0.071 0.057 0.089 0.061 0.048 0.078 0.071 0.057 0.089 0.071 0.057 0.089 0.106 0.088 0.127
125 0.0953 1.1 0.074 0.059 0.092 0.068 0.054 0.085 0.082 0.067 0.101 0.075 0.060 0.093 0.081 0.066 0.100 0.094 0.077 0.114
150 0.0953 1.1 0.063 0.050 0.080 0.070 0.056 0.088 0.062 0.049 0.079 0.075 0.060 0.093 0.078 0.063 0.096 0.116 0.098 0.137
175 0.0953 1.1 0.066 0.052 0.083 0.071 0.057 0.089 0.069 0.055 0.086 0.079 0.064 0.097 0.073 0.058 0.091 0.117 0.099 0.138
200 0.0953 1.1 0.072 0.058 0.090 0.101 0.084 0.121 0.080 0.065 0.098 0.092 0.076 0.112 0.099 0.082 0.119 0.135 0.115 0.158
50 0.1823 1.2 0.068 0.054 0.085 0.090 0.074 0.109 0.065 0.051 0.082 0.091 0.075 0.110 0.093 0.077 0.113 0.111 0.093 0.132
75 0.1823 1.2 0.096 0.079 0.116 0.095 0.078 0.115 0.106 0.088 0.127 0.100 0.083 0.120 0.107 0.089 0.128 0.164 0.142 0.188
100 0.1823 1.2 0.106 0.088 0.127 0.098 0.081 0.118 0.112 0.094 0.133 0.099 0.082 0.119 0.114 0.096 0.135 0.226 0.201 0.253
125 0.1823 1.2 0.115 0.097 0.136 0.127 0.108 0.149 0.135 0.115 0.158 0.132 0.112 0.154 0.145 0.125 0.168 0.261 0.235 0.289
150 0.1823 1.2 0.134 0.114 0.157 0.155 0.134 0.179 0.138 0.118 0.161 0.167 0.145 0.191 0.171 0.149 0.196 0.298 0.270 0.327
175 0.1823 1.2 0.134 0.114 0.157 0.161 0.140 0.185 0.166 0.144 0.190 0.177 0.155 0.202 0.182 0.159 0.207 0.331 0.303 0.361
200 0.1823 1.2 0.145 0.125 0.168 0.189 0.166 0.214 0.175 0.153 0.200 0.191 0.168 0.217 0.215 0.191 0.242 0.360 0.331 0.390
50 0.2624 1.3 0.106 0.088 0.127 0.128 0.109 0.150 0.101 0.084 0.121 0.127 0.108 0.149 0.142 0.122 0.165 0.226 0.201 0.253
75 0.2624 1.3 0.120 0.101 0.142 0.152 0.131 0.176 0.140 0.120 0.163 0.153 0.132 0.177 0.173 0.151 0.198 0.277 0.250 0.306
100 0.2624 1.3 0.145 0.125 0.168 0.208 0.184 0.234 0.178 0.156 0.203 0.200 0.176 0.226 0.234 0.209 0.261 0.383 0.353 0.414
125 0.2624 1.3 0.185 0.162 0.210 0.214 0.190 0.240 0.204 0.180 0.230 0.237 0.212 0.264 0.261 0.235 0.289 0.474 0.443 0.505
150 0.2624 1.3 0.192 0.169 0.218 0.248 0.222 0.276 0.236 0.211 0.263 0.269 0.242 0.297 0.265 0.239 0.293 0.528 0.497 0.559
175 0.2624 1.3 0.229 0.204 0.256 0.275 0.248 0.303 0.257 0.231 0.285 0.299 0.271 0.328 0.325 0.297 0.355 0.595 0.564 0.625
200 0.2624 1.3 0.280 0.253 0.309 0.329 0.301 0.359 0.321 0.293 0.351 0.367 0.338 0.397 0.392 0.362 0.423 0.673 0.643 0.701
50 0.3365 1.4 0.119 0.100 0.141 0.154 0.133 0.178 0.141 0.121 0.164 0.153 0.132 0.177 0.161 0.140 0.185 0.303 0.275 0.332
75 0.3365 1.4 0.184 0.161 0.209 0.195 0.172 0.221 0.212 0.188 0.238 0.209 0.185 0.235 0.240 0.215 0.267 0.410 0.380 0.441
100 0.3365 1.4 0.221 0.196 0.248 0.253 0.227 0.281 0.260 0.234 0.288 0.288 0.261 0.317 0.302 0.274 0.331 0.580 0.549 0.610
125 0.3365 1.4 0.290 0.263 0.319 0.314 0.286 0.343 0.308 0.280 0.337 0.339 0.310 0.369 0.396 0.366 0.427 0.692 0.663 0.720
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Table 1 Statistical power for all simulation settings. Point estimates, as well as Wilson confidence intervals are reported for all analysis approaches (Continued)
Size Treatment OR T-test CI lower CI upper T-test delta CI lower CI upper I-test CI lower CI upper I-test delta CI lower CI upper ANCOVA CI lower CI upper Transitional CI lower CI upper
150 0.3365 1.4 0.309 0.281 0.338 0.376 0.347 0.406 0.374 0.345 0.404 0.404 0.374 0.435 0.442 0.411 0.473 0.736 0.708 0.762
175 0.3365 1.4 0.329 0.301 0.359 0.399 0.369 0.430 0.396 0.366 0.427 0.434 0.404 0.465 0.463 0.432 0.494 0.800 0.774 0.824
200 0.3365 1.4 0.407 0.377 0.438 0.464 0.433 0.495 0.445 0.414 0.476 0.495 0.464 0.526 0.536 0.505 0.567 0.857 0.834 0.877
50 0.4055 1.5 0.162 0.140 0.186 0.178 0.156 0.203 0.196 0.173 0.222 0.190 0.167 0.215 0.210 0.186 0.236 0.392 0.362 0.423
75 0.4055 1.5 0.238 0.213 0.265 0.263 0.237 0.291 0.281 0.254 0.310 0.291 0.264 0.320 0.318 0.290 0.348 0.592 0.561 0.622
100 0.4055 1.5 0.302 0.274 0.331 0.354 0.325 0.384 0.366 0.337 0.396 0.390 0.360 0.421 0.392 0.362 0.423 0.737 0.709 0.763
125 0.4055 1.5 0.368 0.339 0.398 0.443 0.412 0.474 0.420 0.390 0.451 0.467 0.436 0.498 0.515 0.484 0.546 0.825 0.800 0.847
150 0.4055 1.5 0.397 0.367 0.428 0.509 0.478 0.540 0.467 0.436 0.498 0.546 0.515 0.577 0.583 0.552 0.613 0.891 0.870 0.909
175 0.4055 1.5 0.495 0.464 0.526 0.559 0.528 0.589 0.567 0.536 0.597 0.597 0.566 0.627 0.648 0.618 0.677 0.919 0.900 0.934
200 0.4055 1.5 0.530 0.499 0.561 0.616 0.585 0.646 0.598 0.567 0.628 0.669 0.639 0.697 0.706 0.677 0.733 0.967 0.954 0.976
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Fig. 1 Comparison of statistical power for the median treatment
effect. The statistical power of all six approaches for treatment effect
testing are plotted against total trial size (1:1 randomization) for the
median simulated treatment effect βtrt = 0.2624 = log(1.3)
controlling for baseline UEMS: β̂trt = −1.165, p −
value = 0.307.
i-test: No significant dependency between UEMS at 6
months and treatment arm: Z=0.553, p−value=0.58.
i-test delta: No significant dependency between change
in UEMS and treatment arm: Z=1.525, p − value =
0.127.
transitional: No significant shift inmotor score probabil-
ities associated with treatment arm: β̂trt = −0.197,
p − value = 0.207.
Summarizing, all six approached did not show signifi-
cant results at the nominal level 0.05, but they all showed
a tendency to less positive outcomes for patients in the
treatment arm. This analysis is intended to give an exam-
ple of the application for the proposed transitional ordinal
model, but is not intended and should not be taken as a
definitive conclusion about the value or outcome of the
trial.
Discussion
The aim of this simulation study was to compare several
approaches of testing for treatment effect in two-armed
RCT in a neurological setting. We therefore simulated
clinical trials with cervical SCI participants with specific
levels of experimental conditions and tested for treatment
effect with six different approaches. Routinely employed
analysis approaches not only rely on strong assumptions
about the properties of the endpoints being analysed, but
were also outperformed in virtually all settings by the the
proposed autoregressive transitional ordinal model for the
analysis of UEMS.
Adding ordinal endpoints to form a single overall score is
generally not valid
Common approaches to the analysis of UEMS and similar
neurological endpoints are as the total sum of all motor
scores Y ∗i,2 =
∑10
m=1 Yi,m,2 or as difference between two
time points Y ∗∗i =
∑10
m=1 Yi,m,2 − Yi,m,1.
Whether it is appropriate to combine a set of ordinal
variables to generate a total score is usually not checked
in neurology [37]. It should nonetheless be a require-
ment, as there are at least two strong assumptions related
to the analysis of summed motor scores as a metric
endpoint: unidimensionality and equal differences. Uni-
dimensionality refers to the property of several scores to
measure a single, common patient’s characteristic. While
there is some preliminary evidence that unidimension-
ality holds for UEMS [38], the opposite was reported
for both the Functional Independence Measure FIM [39],
the Spinal Cord Independence Measure SCIM [40], a
situation which is very likely to be found in functional
endpoints and Patients Reported Outcomes PRO. Equal
differences imply that a unit change in motor scores rep-
resent exactly the same clinical change, independently of
where the change took place on the scale (e.g. a change
from 0 to 1 is assumed to be of the same magnitude as
a change from 3 to 4 in motor scores), or of which key
muscle are considered (the previous example is assumed
to hold even when the changes took place on different
key muscles, say e.g. one proximal and one distal from the
lesion level).
The widely used method of adding up several ordi-
nal endpoints to form a single overall score is therefore
generally not valid with regard to the two assumptions
exemplified above, and has been repeatedly reported
in neurological and related physical functioning settings
[39–44]. From a practical point of view, biased parameter
estimates, as well as misleading associations and loss of
power are some of the known consequences of assuming
metric property for ordinal endpoints [21–23]. There is
therefore a compelling need to embrace statistical models
specifically designed for the analysis of complex ordinal
endpoints.
RCT simulation
The proposed autoregressive transitional ordinal model
is the first attempt in SCI to model and analyse a com-
plex endpoint with a regression model which reflects
its ordinal nature and takes into account important
prognostic factors. The proposed model for the anal-
ysis of UEMS in cervical SCI patients outperformed
all other approaches in virtually all settings. The sensi-
bly lower statistical power achieved by commonly used
approaches, in addition to their implicit assumptions,
indicate that their use as default analysis methods in not
justified.
- 62 - Paper III
Tanadini et al. BMCMedical ResearchMethodology  (2016) 16:149 Page 9 of 13
Fig. 2 Contour plots of statistical power for all simulation settings. The statistical power of all testing approaches is represented using loess smooth
approximation. Contour curves visualize combinations of trial size and treatment effect with equivalent statistical power, which is reported as
numerical value. The colour key differentiates regions of low statistical power (violet) from regions of high statistical power (blue)
Contrary to our expectations, a stratification of
the t-test based on the Motor Level did not pro-
vide a discernible improvement in statistical power
(Table 1). In fact, even though blocked independence
tests showed a slightly higher power than their corre-
sponding t-tests (Fig. 2), the gain in power was not
such that their application as “ad hoc” solution resulted
substantiated.
In terms of clinical interpretation of treatment effect
estimates, we note that by applying the proposed model,
the exponentiated treatment effect estimate β̂trt can be
interpreted as the conditional odds ratio between the
treatment and control trial arms, which is a common and
accepted way of quantifying treatment effect in the clini-
cal setting. Even when the proportional odds assumption
is not fully met, it still provides an interpretable parame-
ter that summarizes the treatment effect over all levels of
the outcome [23]. In addition, the transitional model pro-
vides motor score probabilities for each combination of
prognostic variables, making the direct comparison and
visual representation of treated and untreated participants
straightforward (see Fig. 3).
On the contrary, clear interpretation of the results pro-
duced by common approaches is precluded by summed
scores of suppositional metric endpoints, providing lit-
tle insight for trial scientists and clinicians. Importantly,
small and possibly localized treatment effects, which are
a hallmark of many neurological disorders, can be disen-
tangled using ordinal approaches for motor scores, but
become lost in the analysis of summed total scores.
Finally, our simulation showed (Table 1) that a statistical
power of 80 %, which is a common goal for clinical trials
planners, is reached by the ordinal model only for large
trial size and large postulated treatment effects. As a total
trial size of N=200 seems to currently represent the prac-
tical upper limit for conducting SCI trials, the statistical
detection of an existing treatment effect seems to rely on
a rather strong effect. Further improvements of the ordi-
nal model will likely result in lowered requirements for
treatment detection.
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Fig. 3 Visualization of median treatment effect βtrt = 0.2624 = log(1.3). In contrast to all other analysis approaches, the transitional ordinal model
allows to graphically represent shifts in motor score distributions for any constellation of relevant prognostic factors, permitting a much more
detailed investigation of treatment effect. As illustrative example, represented is the distribution of motor score probabilities for participants in the
control (left panel) and treatment arm (right panel). Lower scores became less, while higher score became more probable in the treatment arm. The
treatment effect βtrt = 0.2624 = log(1.3) corresponds to an Odds Ratio of OR=1.3.The specific constellation of prognostics factor represented refers
to a C8 key muscle, with a Motor Level C5 (xlev=C5.-3), a baseline motor score of ybase,i,m,1 = 1, and an autoregressive component yauto,i,m−1,2 = 3 for
the motor score of the key muscle just above the one being reported
Revisiting a key SCI trial
To provide a concrete application of our approach, we
analysed a subset of participants of the Sygen® trial
[17, 35, 36]. Many ancillary analyses in the original publi-
cation were based on t-test and ANCOVA approaches and
favoured the treatment group over placebo [17]. In par-
ticular, treated participants showed a faster initial recov-
ery than control subjects, who nonetheless caught up at
slightly later time points.
On the subsample of patients we considered, no one
of the six approaches was significant at the conventional
nominal level 0.05. Nonetheless, all approaches showed
a tendency towards negative effect of treatment on the
UEMS, meaning that treated patient showed on average a
slightly worse recovery than patients in the control arm.
Especially for the ordinal approach, the results imply that
the odds of participants in the treatment group of achiev-
ing up to a given motor score were only eβ̂trt = 0.82 times
the odds of a participant with similar characteristics in
the control arm, indicating a worse recovery for treated
patients.
The negative estimate of treatment effect in cervical par-
ticipants is rather unexpected. The observed unbalance
toward more severe lesions in the treatment arm may
explain at least in part these results, which nonetheless
might be examined more closely to rule out potentially
unintended detrimental effects. Nevertheless, we retain
that generalizations of our results to the overall validity of
the trial and its compound cannot be drawn.
Are summed overall scores not “good enough” ?
In our application, all six approaches presented delivered
comparable results, namely statistically non-significant
negative trends for participants in the treatment arm. One
may therefore wonder what the added value of an ordinal
approach like the proposed transitional ordinal model is.
Briefly, routinely employed approaches based on summed
overall scores imply:
• Unmet assumptions: adding ordinal endpoints to
form a single overall score requires equal differences
across all ordinal scales as well as unidimensionality.
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Both assumptions are usually not further investigated
[37], but the first can be rejected on medical reasons
only, while the latter does not hold for several SCI
endpoints (e.g. FIM [39], SCIM [40]).
• Flawed inference and estimation: known practical
consequences of assuming metric property for
ordinal endpoints are biased parameter estimates and
misleading associations [21–23].
• Reduced statistical power: small and possibly localised
effects are expected to be the hallmark of spinal cord
injury rehabilitation strategies. The simulation
reported provide evidence for a much lower capacity
of approaches based on summed scores to detect
existing treatment effects. Lower power also
translates in higher requirement for trial participants.
• Unclear interpretation of treatment effect: a clear
interpretation of treatment effect estimates as
conditional OR, which can be visualised for each key
muscle separately (see Fig. 3), is not possible for
summed scores.
• Limited future extensions: future refinement of
routinely employed approaches are strongly limited
by the underlying, inappropriate analysis approach.
Instead, ordinal approaches, which are based on a
regression framework, easily accommodates for
extensions (e.g. further prognostic factors,
interactions, localised effects).
Concluding, from a theoretical point of view, routinely
employed approaches have little scientific validity and
have been replaced by more rigorous approaches. Even
more importantly, they are also potentially misleading on
practical terms. Our flexible model represents therefore
an improved and pragmatic solution to the analysis of this
type of complex ordinal endpoints.
Brain Injury: similar issues, similar solutions
We observe that most of the discussion points we raised
link to the report by the International Mission on Prog-
nosis and Clinical Trial Design in Traumatic Brain Injury
TBI [45]. TBI is a related clinical field which faced very
similar challenges, mainly related to the heterogeneity of
the patient population, and had a similar history of clinical
testing as SCI.
In fact, TBI also experienced a disappointing progres-
sion of clinical testing of treatment interventions in spite
of extremely promising pre-clinical data and early phase
trials. Maas et al. [45] reported that a key difficulty has
been the inherent heterogeneity TBI subjects, and that the
observed development was due, at least to some extent, to
limitations in the trial designs and analyses. Both aspects
have also been reported as hallmarks of SCI research.
Summarizing, The TBI Mission solicited the TBI com-
munity to [45]:
• provide details of the major baseline prognostic
characteristics
• broaden inclusion criteria as much as is it compatible
with the current understanding of the mechanisms of
action of the intervention
• incorporate pre-specified covariate adjustment into
the statistical analysis
• use an ordinal approach for the statistical analysis
A part from the first recommendation, which is mainly
concerned with the way clinical studies are reported, the
following three points regard the planning and especially
the analysis of clinical trials in TBI, and are implemented
in this publication. Selection of patients is based only on
the initial Motor Level, which relates to the understand-
ing of motor function. The proposed model (see Eq. 2)
both include the most relevant covariates adjustment,
namely baseline motor scores as well as motor lesion, and
uses and ordinal approach for ordinal data based on the
proportional odds model.
Latent variable models: an improved, readily available
framework
More generally speaking, the statistical foundations of
regression models for ordinal endpoints were developed
more than 4 decades ago [46–48], and have ever since
undergone a steady development. There is a huge body of
literature pertaining to the analysis of ordinal variables,
including Item Response Theory IRT and mixed-effects
models for ordinal variables [49]. Despite this develop-
ment, most clinical trials in neurology still rely on sur-
passed approaches [44], corroborating the negative trend
of methodological errors related to the analysis of ordinal
scales in medical research [50].
The proposed transitional ordinal model (Eq. 2) is an
extension of the well known proportional odds model
(e.g. [51]). The latter can be seen as an important spe-
cial case within the IRT framework, and is closely related
to the Rasch model [46]. All these statistical models are
generally referred to as latent variable models, because
they find application in situations where a set of ordi-
nal variables are seen as indicators of a latent variable.
This latent variable is the main interest of the analysis,
and, although it cannot be measured directly, it can be
inferred from the available ordinal variables. The latent
variable approach seems both appropriate and appealing
for applications in the clinical setting, and the transitional
ordinal model proposed draws a concrete link from SCI to
latent variable models. Further extensions of our approach
can be tailored to the analysis of other endpoints such
as functional assessments and PROs. In fact, the analy-
sis of PRO, and the related trial powering based on Rasch
models has recently received much attention [52, 53].
We believe that the transition from currently employed
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analysis approaches to more sophisticated models within
the readily available framework of latent variable mod-
els would represent a great scientific progression for the
planning and analysis of complex neurological endpoints.
Conclusion
We propose an autoregressive transitional ordinal model
for the analysis of a specific SCI endpoint which takes
into account the complex ordinal nature of the endpoint
under investigation and explicitly accounts for relevant
prognostic factors. Superior statistical power in virtually
all settings, combined with a clear clinical interpretation
of treatment effect and widespread availability on com-
mercial softwares, are strong arguments for clinicians and
trial scientists to adopt, and further refine, the proposed
approach.
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Abstract
Background. Despite the ubiquity of multiple-item rating scales used to mea-
sure health outcomes in patients with neurological disorders, current analysis
approaches present several limitations and represent a major weakness of the
translational process.
Methods. We conducted a retrospective analysis of prospectively collected lon-
gitudinal data of patients who suffered a spinal cord injury with the goal to
assess metric properties and dimensionality of a multiple-item neurological rat-
ing scale. In addition, we propose an approach for the longitudinal modeling of
neurological recovery after injury. All analyses were performed with the unify-
ing framework of latent variable modeling and involved latent trait analysis and
latent curve modeling techniques.
Findings. The analysis provided evidence that the multiple-item primary end-
point Upper Extremity Motor Score behaves as an ordinal scale, but, due to
varying loadings across key muscles, its analysis as a total sum score will be
insufficient as a measure of the attribute. In addition, unidimensionality holds
only for a subset of the initially selected patient population. We found strong
evidence that the key muscles composing the Upper Extremity Motor Score
on the left and right body sides measure the same latent construct, allowing
important simplification in following analysis steps. The longitudinal modeling
reported a strong negative correlation between intercept and slope terms.
Interpretation. Our comprehensive study represents a concrete solution for the
analysis of a complex neurological endpoint that avoids commonly used, but
flawed approaches. It is further intended to act as a template for the assessment
of metric properties and analysis of multiple-item rating scales across medical
disciplines.
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Research in context.
Evidence before this study Two review articles comprehensively sum-
marize the scientific evidence considered before this study. Hobart (2007) re-
ported that methodological limitations of rating scales are an important cause
of clinical failure of very promising therapeutic approaches in neurology. An
historical revision of key studies in the field of spinal cord injury by Lammertse
(2012) reveals that multiple-item rating scales are consistently analyzed as sin-
gle overall summed scores. Nonetheless, those approaches have been shown to
be inappropriate in many aspects.
Added value of this study Our comprehensive investigation of a fre-
quently used neurological endpoint in spinal cord injury trials assessed metric
properties and proposed a longitudinal endpoint analysis based on the unifying
framework of latent variable modeling. Our study exemplifies theoretical and
practical drawbacks of commonly used approaches, and proposes a concrete so-
lution based on a much more rigorous and sophisticated statistical framework.
Implications of all the available evidence Our findings support the
concern that methodological limitations of rating scales in neurology are a major
factor contributing to the failure of many clinical studies in this field. Our results
provide a concrete solution to investigating metric properties and analyzing a
primary endpoint generated by multiple-item rating scales. While basing our
analysis on a function-based neurological endpoint often applied in spinal cord
injury, the content of our paper is highly relevant to all neurological disciplines.
Not only are multiple-item rating scales omnipresent in all fields of neurology,
but our analyses are also intended to act as a template for the assessment of
this type of endpoints across neurology.
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1. Introduction
Neurological research is responsible for the investigation of many devastating
disorders, with the ultimate goal of delivering effective treatments to patients.
Many discoveries from basic research and clinical investigation have entered
the translational process, which seems to be based on optimal premises due to
the acceleration in understanding of brain plasticity and the economic poten-
tial of any drug that obtained approval from regulatory agencies. In fact, with
yearly health costs for European society estimated at almost 400 billion e [1],
brain-related disorders are a greater socio-economic burden than cancer, car-
diovascular diseases and diabetes combined [2]. Despite the obvious economic
interest, health insurers and drug companies have nonetheless withdrawn from
neuroscience as a consequence of the large number of failed trials [3].
The question therefore arises as why very promising approaches have failed
to deliver treatments in humans. In line with others [4], we maintain that major
weaknesses of the translational process are to be located in the methods used to
test for efficacy of treatment in rating scales used to measure health outcomes
in patients. There are, in fact, two often overlooked limitations of multiple-
item rating scales that are particularly relevant. Firstly, the ordinal numbers
generated by rating scale items are characterized by arbitrary integers solely
establishing a ranking. This implies that the difference between two following
ranks is by no means bound to be equivalent in clinical terms, and a given
difference in total score usually does not have the same meaning across the
scale range [5]. Secondly, instead of a single, unidimensional health domain,
many neurological multiple-item rating scales measure a combination of several
domains. While this may seem to be a rather theoretical issue far away from
clinical practice, it means having a scale that measures “length at one end,
weight in the middle, and volume at the other end” [5].
Nonetheless, multiple-item rating scale measurements are usually taken at
face values and handled as continuous, interval-scaled measurements and often
combined in a total summed score before analysis. Such an approach has been
shown to be inappropriate in a number of aspects [6], with consequences such as
biased parameter estimates, misleading associations and loss of power [7, 8, 9].
Despite all these issues, ordinal measurements generated by multiple-item
rating scales are often the only type of data which clinical assessments provide
and thus what neurologists have to work with [5]. To overcome shortcomings
of currently employed approaches, we assess metric properties and dimension-
ality of a multiple-item neurological rating scale and we propose an approach
for the longitudinal modeling of neurological recovery based on latent variable
modeling. This not only places it in a much more rigorous and sophisticated in-
ferential framework, it also provides a template applicable to similar endpoints
across medical fields.
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2. Methods
The objective of this study was to propose an approach to the analysis of
complex ordinal endpoints which overcomes drawbacks of common approaches
in neurology. We report a comprehensive analysis of a multiple-item rating scale
particularly relevant in spinal cord injury research, providing a widely applicable
template for the assessment of its metric properties and for its longitudinal
analysis under the unifying framework of latent variables.
Patient population and study design. For our retrospective analysis of prospec-
tively collected longitudinal data, we utilised records of N=782 de-identified
individuals extracted from the European Multicenter Study about Spinal Cord
Injury (EMSCI, ClinicalTrials.gov). EMSCI tracks, in a highly standardized
manner, the functional and neurological recovery of patients at 1, 4, 12, 24,
48 weeks after spinal cord injury. All examinations were performed by trained
staff according to the International Standards for Neurological Classification
of Spinal Cord Injuries [10]. The Ethical Committee of the Canton of Zurich,
Switzerland, approved the EMSCI project and any statistical analysis thereof.
Primary endpoint. The primary focus of our analyses was the Upper Extremity
Motor Scores (UEMS), which is a particularly relevant neurological endpoint in
the field of spinal cord injury [11, 12, 13]. UEMS measures the muscle contrac-
tion force for 10 key muscles on the arms and hands. On each body side, the
elbow flexors (C5), wrist extensors (C6), elbow extensors (C7), finger flexors
(C8), and little finger abductors (T1) are tested. Each key muscle is rated on a
6-point rating scale with the following muscle function grading: “total paraly-
sis” (score 0), “palpable or visible contraction” (score 1), “active movement, full
range of motion (ROM) with gravity eliminated” (score 2), “active movement,
full ROM against gravity” (score 3), “active movement, full ROM against grav-
ity and moderate resistance in a muscle specific position” (score 4), “normal
active movement, full ROM against gravity and full resistance in a functional
muscle position expected from an otherwise unimpaired person” (score 5).
Statistical analysis. Latent variable modeling, of which factor analysis is the
oldest and most widely used, finds applications in all situations where the vari-
able of major interest cannot be measured directly [14]. Instead, a set of ob-
servable variables called indicators (the key muscles) are measured and used to
make inference about the latent variable of interest (neurological status). For
the specific neurological settings outlined here, where all indicators are mea-
sured on rating scales, and the latent variables inferred are supposedly metrical,
the techniques are collectively referred to as Latent Trait Analysis (LTA). LTA
methods have a common mathematical formulation described in Equations 1 -
3. Let suppose that the observed item scores (e.g. the rating of the ten key
muscles composing the UEMS) are denoted by x1,...,xp, and that there are mi
ordered categories for item i. Let pii(s)(f) be the probability that, given the
latent variables f, a measurement delivers response category s to item i. The
category response function pii(s)(f) (Equation 1) can be expressed in terms of
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difference between adjacent cumulative response functions (Equation 2), and
thus the model is written as indicated in Equation 3.
pii(s)(f) = γi(s)(f)− γi(s−1)(f) (1)
γi(s)(f) = P (xi ≤ s | f) = pii(1)(f) + pii(2)(f) + ...+ pii(s)(f) (2)
log
[
γi(s)(f)
1− γi(s)(f)
]
= αi(s) −
q∑
j=1
αijfj (3)
where s = 1, ..., mi, i = 1, ..., p and fj ∼ N(0,1) for j = 1, ..., d are independent
standard normal distributions. The model represented in Equation 3 is also
known as the proportional odds model [15]. The factor loadings αij quantify
how the probability distributions of key muscle scores are influenced by the
position of a given patient on the latent variables fj (e.g. his neurological status).
Metric properties and dimensionality Firstly, we performed an ex-
ploratory nominal LTA [16] to assess whether the key muscles behave as intended
as a rating scale. This analysis was conducted using all SCI patients assessed
at one week after injury (t = 1), and for left and right body parts separately.
As the factor loadings show the increase in the odds of falling into a response
category as the position of a given patient on the latent variable increases, a
situation in which the ordered factor loadings increased in magnitude would be
an indication that the items are indeed measured on an ordinal scale [14]. In
addition, the standardized loadings provide insight into the validity of summing
all motor scores in an unweighted total score. In fact, when the standardized
loadings vary between items, the analysis based on the unweighted sum of all
motor scores (e.g. total UEMS) is invalid [14].
Secondly, we performed an ordinal LTA to assess the dimensionality of
UEMS. A desirable property of rating scales is that all items are indicators of a
single, unidimensional latent health domain. The dimensionality is assessed by
fitting LTA models with an increasing number of latent dimensions, which are
then compared in terms of model fit to determine how many latent variables
are necessary to best reproduce the observed data. Model fit was assessed by
looking at the fits to the one- and two-way margins, where standardized Chi-
square type residuals greater than 4 would indicate poor fit [14]. In addition,
model selection criteria such as the Akaike Information Criterion (AIC) and the
Bayesian Information Criterion (BIC) provided additional elements of guidance
for model selection [17]. This analysis was conducted for all SCI patients, sepa-
rately for each time point and for each body side. Given that UEMS measures
five key muscles on each body side, we fitted 1- and 2-dimensional LTA models.
Thirdly, we ran a Confirmatory Factory Analysis (CFA) to assess whether
key muscles on the right and left body sides are measuring the same latent
construct. A two-factor CFA was fitted to the left and right body sides, with
Paper IV - 75 -
indicators from each side loading on a separate latent variable, which were
allowed to correlate. A high correlation of the left and right latent variables
would be a strong indication that both sets of 5 key muscles are indeed measuring
the same latent construct. This analysis was conducted for all cervical SCI
participants, separately for each time point.
Longitudinal modeling The longitudinal evolution of the neurological
status measured by UEMS, and indeed all multiple-item rating scales, can
also be modeled within the framework of latent variables by applying a La-
tent Growth Curve Model (LGCM) [18]. As for previous analysis, the key
muscles are used as indicators of the underlying continuous neurological status.
In addition, the inferred multiple measurements of neurological status at differ-
ent time points are seen themselves as indicators of latent variables describing
the intercept and slope components of the trajectory modelled as graphically
represented in Figure 1. By applying LGCM, we achieve a flexible model with
patient-specific trajectories of neurological recovery over time [19].
  
C5 C6 C7 C8 T1
NS
1 week
NS
4 weeks
NS
24 weeks
Intercept
(I)
Slope
(S)
Covariates
C5 C6 C7 C8 T1C5 C6 C7 C8 T1
Figure 1: Simplified path diagram representing the dependencies among key muscles as indi-
cators (top boxes), the latent variables quantifying the neurological status (NS) at different
time points (top circles), which act themselves as indicators for further latent variables coding
for the intercept (I) and slope (S) components of the longitudinal model (bottom circles).
Baseline covariates were allowed to directly influence both intercept and slope (bottom box).
The longitudinal modeling of UEMS was conducted including all cervical SCI
patients at 1, 4 and 24 weeks after injury. Only at these time points, the extent
of missing data on all key muscles was marginal (12%, 11%, 7% respectively)
and the condition of data missing at random still plausible. The missing key
muscles are treated with the direct Maximum Likelihood (ML) approach, which
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maintains the ML properties under the assumption of missing at random [20].
The availability of three time points allowed only the formulation of models for
a linear recovery. Nonetheless, the focus of this manuscript is the application of
latent variables models to neurological situations requiring it, rather than the
detailed modeling of the recovery shape.
Routinely available covariates collected at baseline such as gender, height,
age at injury, year of injury, and motor level (right body side) were allowed to
directly influence both the intercept and slope components of the LGCM in a
classical regression fashion (see lower part Figure 1). In future studies, further
variables such as treatment arm can be added in a straightforward manner,
providing a test for treatment effect in the longitudinal analysis of neurological
endpoints. The utility of LGCM in treatment comparisons and their ability
to address possible differences in the initial conditions of trial participants in
different trial arms have been reported before [19].
All computations were performed with Mplus (version 7.11). Nominal LTA
was performed with LAMI (freely available at LAMI). Input files are provided
as supplementary web material.
Role of the funding sources. The entities providing financial support had no role
in study design, data collection, data analysis, data interpretation, or writing
of the report. The authors had full access to all the data in the study and had
final responsibility for the decision to submit for publication.
3. Results
Metric properties and dimensionality. Firstly, we performed an exploratory
nominal Latent Trait Analysis (LTA) to assess whether the Upper Extremity
Motor Score (UEMS) behaves as intended as a rating scale. Table 1 shows the
standardized loadings for the left and the right body sides, which were analyzed
independently at 1 week after injury.
For both sides of the body, the estimated loadings of each key muscle show
a pattern of increasing loadings with increasing category, implying an increase
in the odds of falling into a given category compared to the reference category
with an increase in the patient position on the latent variable. In addition, the
estimated loadings stαij(s) vary between 0.5100 to 0.9962 and are therefore not
of similar magnitude. This finding does not support the use of the sum score as
the unit of analysis.
Secondly, we performed an ordinal LTA to assess the dimensionality of
UEMS. A desirable property of rating scales is that all indicators load on a
single, unidimensional latent health domain. The goodness-of-fit of LTA mod-
els with increasing number of latent traits was assessed by looking at the fits
to the one- and two-way margins, where standardized residuals greater than 4
would indicate poor fit [14].
An important number of residuals indicated poor model fit. The majority of
standardized residuals that needed closer attention regarded category 5 of the
motor scores. Especially the combinations of scores 5 and 5, independently of
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Table 1: Nominal Latent Trait Analysis: standardized factor loadings of the one-factor model
for all patients at 1 week after injury.
Key muscle Score category (reference is 0) Left body side Right body side
C5 1 0.5100 0.8834
C5 2 0.8609 0.9057
C5 3 0.8845 0.9368
C5 4 0.9510 0.9580
C5 5 0.9865 0.9863
C6 1 0.7190 0.5553
C6 2 0.8452 0.8589
C6 3 0.9120 0.9397
C6 4 0.9761 0.9771
C6 5 0.9951 0.9950
C7 1 0.5795 0.6406
C7 2 0.8768 0.8979
C7 3 0.9481 0.9493
C7 4 0.9818 0.9829
C7 5 0.9956 0.9957
C8 1 0.8771 0.8281
C8 2 0.9371 0.8715
C8 3 0.9750 0.9710
C8 4 0.9835 0.9852
C8 5 0.9959 0.9962
T1 1 0.8990 0.8579
T1 2 0.9571 0.9423
T1 3 0.9685 0.9580
T1 4 0.9843 0.9861
T1 5 0.9954 0.9954
key muscle, produced the largest positive residuals in the one-factor model, in-
dicating that the misfit is predominantly due to a unexpectedly large frequency
of motor scores 5 compared to the model-based expectations. Even though the
number of standardized residuals indicating poor fit was less severe for data at
4 and 24 weeks, the extent of misfit for EFA at 1 week after injury, and espe-
cially the one-factor model, prompted us to restrict the analysis to patients who
suffered a spinal cord injury in the cervical region. Cervical patients represent a
clinically relevant cohort, and we assumed that their high level of lesion would
mitigate the excess of maximal muscle score leading to the severe misfit reported
in Table 2. We therefore ran an ordinal LTA including only cervical patients to
assess the dimensionality of UEMS, which is reported in Table 3.
Also for this model, the estimated loadings varied across items and therefore
the total sum score will be insufficient as a measure of the attribute.
Thirdly, we ran a Confirmatory Factory Analysis (CFA) to assess whether
there is indication that key muscles on the right and left body sides are mea-
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Table 2: EFA for UEMS (left body side), all patients at Week 1 after injury (N=689): count of
standardized residuals (z-scores) > |4| from the two-way margins. Counts concerning UEMS
score 5 are reported in brackets.
One-factor model Two-factor model
Items C6 C7 C8 T1 Items C6 C7 C8 T1
C5 3 (3) 2 (2) 3 (3) 3 (3) C5 0 0 0 0
C6 4 (4) 2 (2) 2 (2) C6 0 1 (0) 0
C7 1 (1) 1 (1) C7 1 (1) 1 (0)
C8 2 (1) C8 0
Table 3: One-factor EFA for UEMS (left body side), cervical patients at 1, 4, 24 weeks after
injury: count of standardized residuals (z-scores) > |4| from the two-way margins of the
one-factor model. Counts concerning UEMS score 5 are reported in brackets.
1 week (N=195) 4 weeks (N=223) 24 weeks (N=218)
Items C6 C7 C8 T1 C6 C7 C8 T1 C6 C7 C8 T1
C5 0 0 0 0 0 0 0 0 1 (1) 0 0 0
C6 0 0 0 0 0 0 0 1 (0) 0
C7 0 0 1 (1) 0 1 (1) 0
C8 0 0 0
suring the same latent construct. A two-factor CFA model was fitted to the
left and right body side, with indicators from each side loading on a separate
latent variable, which were allowed to correlate. A high correlation of the left
and right latent variables would be a strong indicator that both sets of 5 key
muscles are indeed measuring the same latent construct. Correlation analyses
were conducted for all cervical participants, separately for each time point, and
delivered correlation coefficients (S.E.) of 0.936 (0.019) at 1 week, 0.915 (0.023)
at 4 weeks, and 0.931 (0.022) at 24 weeks.
Longitudinal modeling. The longitudinal development of UEMS was modelled
within the framework of latent variables by applying a Latent Growth Curve
Model (LGCM) as depicted in Figure 1. The multiple measurements at different
time points are considered indicators for further latent variables describing the
intercept and slope components of the trajectory. The application of LGCM
with categorical indicators requires measurement invariance across time points.
The patterns of factor loadings are reported in Table 4 and are in line with the
assumptions of LGCM.
As the number of thresholds for key muscle C5 on both sides of the body var-
ied across time points, we decided to drop this indicator from further analyses.
Within the framework of latent variable modeling, one may opt to include the
key muscle C5 in the analysis by constraining it to be invariant, but this goes
beyond the scope of this manuscript. Parameter estimates for latent growth fac-
tors as well as significant regression coefficients are presented in Table 5. There
was a strong negative correlation between intercept and slope terms, meaning
that participants with an initial high neurological status did not recover much
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Table 4: Factor loadings of the 2-factor CFA model for cervical patients at different time
points, one latent factor for each body side
1 week 4 weeks 24 weeks
Right Left Right Left Right Left
C5 0.757 0.856 0.520 0.510 0.731 0.481
C6 1.849 1.967 1.582 1.710 1.404 1.346
C7 3.619 3.338 3.282 3.491 2.640 2.805
C8 10.328 13.481 8.091 7.494 8.327 7.835
T1 6.994 7.964 7.374 6.092 6.072 7.129
over time (low slope), and vice-versa. Also, the initial Motor Level seemed to
have a rather strong effect on the intercept term, which describes the inital
neurological status.
Table 5: Latent curve model estimates with covariates influencing the latent growth factors
intercept (I) and slope (S).
Parameter Estimate Standard Error Two-tailed P-values
Intercept I 0 0 (fixed)
Variance I 16.445 3.967 0.000
Intercept S 205.575 159.019 0.196
Variance S 0.879 0.299 0.003
Correlation S, I -0.788 0.310 0.011
Regression coefficient Estimate Standard error Two-tailed P-values
Age at injury on I 0.048 0.021 0.023
Motor level on I 3.171 0.421 0.000
Motor level on S -0.450 0.141 0.001
4. Discussion
Complex ordinal endpoints generated by multiple-item rating scales are ubiq-
uitous in neurology, and often represent the only data format which clinical as-
sessments provide [5]. While the issue related to their inappropriate statistical
analysis is not new in medicine [21], it has grown to such an extent to be con-
sidered a major weakness of the translational process [4]. In Spinal Cord Injury
(SCI), virtually all clinical assessments produce complex ordinal data [10], but
are usually analyzed in ways that discard their ordinal nature [11, 22, 23, 24, 25].
The results of our nominal Latent Trait Analysis (LTA) (see Table 1) pro-
vided support for the ordinality of the key muscles, a property which has been
so far assumed without further investigation. Further, the observed pattern of
larger loading within key muscles is in line with expectations, as higher scores
are assigned to patients able to perform more complex motor tasks [10]. No
general pattern could be recognized among key muscles. The lack of a clear
pattern is probably due to the initial inclusion of patients with different lesion
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levels, as the relevance of the motor level for motor recovery has been reported
before [26, 27]. The same analysis revealed that standardized loadings varied
between key muscles, making commonly employed analysis approaches based
on the (unweighted) total sum of all motor scores an insufficient or even invalid
measure of the neurological attribute.
Ordinal LTA prompted us to restrict our analysis to participants with a cer-
vical motor lesion in order to assure unidimensionality of the Upper Extremity
Motor Scores (UEMS) (see Table 2-3). While some SCI studies focused on the
clinically relevant subset of cervical patients, many did not (e.g. 11, 24). All
these results provide strong evidence against the default application of total
summed UEMS indiscriminately to all patients included into a clinical study.
The Latent Growth Curve Model (LGCM) (see Figure 1) was fitted in or-
der to demonstrate the need for better modeling strategies for complex ordinal
endpoints. The availability of three time points allowed only the formulation
of models for a linear recovery, which we acknowledge is a simplification [28].
Nonetheless, the focus of this manuscript is the application of latent variables
models to neurological situations requiring it, rather than the detailed modeling
of the recovery shape. In line with clinical expectations [26, 27], the model sug-
gested that the initial motor level is a relevant prognostic factor that should be
accounted for in the analysis of UEMS. The other significant prognostic factor
Age at injury played only a marginal role. Instead, the negative correlation be-
tween the intercept and slope terms seems to suggest a rather strong trade-off
between initial level of injury and recovery, which may be indicative of further
issues concerning the measurement tool UEMS as whole.
5. Conclusion
The failure of any clinical study can always be attributed to multiple causes.
It is, nonetheless, remarkable how often the choice of complex ordinal endpoints
and their statistical analyzes are reported among those reasons [29, 30]. De-
spite the fact that the statistical foundations of regression models for ordinal
endpoints were developed several decades ago [31, 32, 33] and have undergone
a steady development, a large number of clinical trials in neurology still rely
on surpassed approaches [4]. The statistical analyses performed here aimed
at assessing the metric properties and longitudinal evolution of a common pri-
mary endpoint in Spinal Cord Injury. The unifying framework of latent variable
modeling adopted is intended to replace commonly used, but flawed analysis ap-
proaches. The progression reported can be used as a template for the analysis
of any multiple-item rating scale across medical fields. Although the mathemat-
ical foundation of those methods can be quite challenging [4], they provide a
huge potential to change the face of health outcomes measurement [5] by plac-
ing the analysis of complex ordinal endpoints within a much more rigorous and
sophisticated inferential framework.
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